[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 10591
1. Meliopoulos VA, Karlsson EA, Kercher L, Cline T, Freiden P, Duan S, Vogel P, Webby RJ, Guan Y, Peiris M, Thomas PG, Schultz-Cherry S: Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism. J Virol; 2014 Nov;88(22):12982-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since emerging in 2013, the avian-origin H7N9 influenza viruses have resulted in over 400 human infections, leading to 115 deaths to date.
  • Although the epidemiology differs from human highly pathogenic avian H5N1 influenza virus infections, there is a similar rapid progression to acute respiratory distress syndrome.
  • Both H5N1 and H7N9 viruses are capable of causing lethal infections, with mortality correlating most strongly with wider distribution of viral antigen in the lungs, rather than with traditional measures of virus titer and host responses.
  • Strain-specific differences included hypercytokinemia in H5N1 infections that was not seen with the H7N9 infections regardless of lethality.
  • Initial reports of H7N9 infection compared them to infections caused by highly pathogenic avian (HPAI) H5N1 viruses.
  • We compared these responses in both in vitro and in vivo models, and found that H5N1 and H7N9 infections exhibit distinct pathological, immunological, and tissue tropism differences that could explain differences in clinical disease and viral transmission.
  • [MeSH-major] Cytokines / secretion. Influenza A Virus, H5N1 Subtype / immunology. Influenza A Virus, H5N1 Subtype / physiology. Influenza A Virus, H7N9 Subtype / physiology. Influenza, Human / virology. Orthomyxoviridae Infections / virology. Viral Tropism

  • MedlinePlus Health Information. consumer health - Bird Flu.
  • MedlinePlus Health Information. consumer health - Flu.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2014, American Society for Microbiology. All Rights Reserved.
  • [Cites] J Virol. 2000 Feb;74(3):1443-50 [10627555.001]
  • [Cites] J Pain Symptom Manage. 2014 Jun;47(6):e5-7 [24685725.001]
  • [Cites] Nature. 2006 Mar 23;440(7083):435-6 [16554799.001]
  • [Cites] J Virol. 2006 Dec;80(24):11960-7 [17005658.001]
  • [Cites] N Engl J Med. 2008 Jan 17;358(3):261-73 [18199865.001]
  • [Cites] Clin Infect Dis. 2009 Jul 15;49(2):279-90 [19522652.001]
  • [Cites] Trends Immunol. 2009 Dec;30(12):574-84 [19864182.001]
  • [Cites] PLoS Pathog. 2010;6(10):e1001136 [20949074.001]
  • [Cites] Vet Res Commun. 2009 Dec;33(8):895-903 [19662506.001]
  • [Cites] Biochim Biophys Acta. 2012 Jan;1824(1):186-94 [21801859.001]
  • [Cites] J Infect Dis. 2012 Jan 15;205(2):252-61 [22147799.001]
  • [Cites] J Virol. 2013 Feb;87(3):1411-9 [23152519.001]
  • [Cites] N Engl J Med. 2013 May 16;368(20):1888-97 [23577628.001]
  • [Cites] MBio. 2013;4(4). pii: e00362-13. doi: 10.1128/mBio.00362-13 [23820393.001]
  • [Cites] Lancet. 2013 Jul 13;382(9887):129-37 [23803488.001]
  • [Cites] Nature. 2013 Jul 25;499(7459):496-9 [23787694.001]
  • [Cites] Nature. 2013 Sep 26;501(7468):551-5 [23842494.001]
  • [Cites] Am J Pathol. 2013 Oct;183(4):1137-43 [24029490.001]
  • [Cites] PLoS One. 2013;8(9):e74863 [24073225.001]
  • [Cites] Ren Fail. 2013;35(10):1466 [23992125.001]
  • [Cites] Clin Infect Dis. 2014 Jan;58(2):242-6 [24076969.001]
  • [Cites] J Virol. 2014 Feb;88(3):1502-12 [24227867.001]
  • [Cites] J Infect Dis. 2014 Feb 15;209(4):551-6 [23990570.001]
  • [Cites] J Virol. 2014 Mar;88(6):3127-34 [24371069.001]
  • [Cites] J Infect Dis. 2014 May 1;209(9):1343-53 [24133191.001]
  • [Cites] ILAR J. 2000;41(2):80-6 [11406701.001]
  • (PMID = 25210188.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Grant] United States / PHS HHS / / HHSN266200700005C
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytokines
  • [Other-IDs] NLM/ PMC4249090
  •  go-up   go-down


2. Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L: Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012. Clin Infect Dis; 2013 Jul;57 Suppl 1:S12-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.
  • BACKGROUND: Thirteen human infections with an influenza A(H3N2) variant (H3N2v) virus containing a combination of gene segments not previously associated with human illness were identified in the United States from August 2011 to April 2012.
  • Because laboratory confirmation of influenza virus infection is only performed for a minority of ill persons and routine clinical tests may not identify H3N2v virus, the count of laboratory-confirmed H3N2v virus infections underestimates the true burden of illness.
  • RESULTS: We estimate that the median multiplier for children was 200 (90% range, 115-369) and for adults was 255 (90% range, 152-479) and that 2055 (90% range, 1187-3800) illnesses from H3N2v virus infections may have occurred from August 2011 to April 2012, suggesting that the new virus was more widespread than previously thought.
  • Continued surveillance is needed to ensure timely detection and response to H3N2v virus infections.
  • [MeSH-minor] Adult. Animals. Child. Female. Humans. Influenza A Virus, H1N1 Subtype / genetics. Male. Orthomyxoviridae Infections / epidemiology. Orthomyxoviridae Infections / transmission. Orthomyxoviridae Infections / veterinary. Population Surveillance. Swine. Swine Diseases / epidemiology. Swine Diseases / transmission. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Flu.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Infect Dis. 2002 Jan 15;185(2):147-52 [11807687.001]
  • [Cites] Vaccine. 2003 May 1;21(16):1762-8 [12686091.001]
  • [Cites] Epidemiol Infect. 1993 Feb;110(1):145-60 [8432318.001]
  • [Cites] Emerg Infect Dis. 2009 Dec;15(12):2004-7 [19961687.001]
  • [Cites] Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S27-35 [21342896.001]
  • [Cites] Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43 [21342897.001]
  • [Cites] Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82 [21342903.001]
  • [Cites] Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S90-3 [21342906.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2011 May 13;58(53):1-100 [21566560.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1213-5 [21900876.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1615-7 [22129996.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2012 Jan 6;60(51-52):1741-4 [22217624.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2012 Jul 27;61(29):561 [22832938.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):619-21 [22895386.001]
  • [Cites] Am J Public Health. 2012 Oct;102(10):e21-6 [22897525.001]
  • (PMID = 23794726.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Grant] United States / Intramural CDC HHS / / CC999999
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ HHSPA727973; NLM/ PMC4603749
  • [Keywords] NOTNLM ; influenza / influenza A(H3N2) variant / prevalence
  •  go-up   go-down


3. Lindsey NP, Prince HE, Kosoy O, Laven J, Messenger S, Staples JE, Fischer M: Chikungunya virus infections among travelers-United States, 2010-2013. Am J Trop Med Hyg; 2015 Jan;92(1):82-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chikungunya virus infections among travelers-United States, 2010-2013.
  • We identified laboratory-confirmed chikungunya virus infections with diagnostic testing performed in the United States from 2010 through 2013.
  • From 2010 through 2013, 115 laboratory-confirmed chikungunya virus infections were identified.
  • No locally-acquired infections were identified.

  • Genetic Alliance. consumer health - Chikungunya.
  • MedlinePlus Health Information. consumer health - Chikungunya.
  • MedlinePlus Health Information. consumer health - Traveler's Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The American Society of Tropical Medicine and Hygiene.
  • [Cites] J Clin Microbiol. 2000 May;38(5):1823-6 [10790107.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):500-1 [24898168.001]
  • [Cites] J Clin Microbiol. 1976 Dec;4(6):503-10 [1002829.001]
  • [Cites] J Gen Virol. 1989 Jan;70 ( Pt 1):37-43 [2543738.001]
  • [Cites] Emerg Infect Dis. 2007 May;13(5):764-7 [17553261.001]
  • [Cites] Clin Chem. 2007 Aug;53(8):1408-14 [17586592.001]
  • [Cites] Lancet. 2007 Dec 1;370(9602):1840-6 [18061059.001]
  • [Cites] Pathol Biol (Paris). 2007 Dec;55(10):490-4 [17920211.001]
  • [Cites] Emerg Infect Dis. 2008 Mar;14(3):416-22 [18325256.001]
  • [Cites] Clin Infect Dis. 2008 Aug 15;47(4):469-75 [18611153.001]
  • [Cites] Clin Infect Dis. 2009 Sep 15;49(6):942-8 [19663604.001]
  • [Cites] Clin Infect Dis. 2011 Mar 1;52(5):e121-6 [21242326.001]
  • [Cites] Antiviral Res. 2013 Sep;99(3):345-70 [23811281.001]
  • [Cites] Lancet. 2014 Feb 8;383(9916):514 [24506907.001]
  • [Cites] J Clin Microbiol. 2000 May;38(5):1827-31 [10790108.001]
  • (PMID = 25349374.001).
  • [ISSN] 1476-1645
  • [Journal-full-title] The American journal of tropical medicine and hygiene
  • [ISO-abbreviation] Am. J. Trop. Med. Hyg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC4347397
  •  go-up   go-down


Advertisement
4. Anderson ME, Lefebvre SL, Rankin SC, Aceto H, Morley PS, Caron JP, Welsh RD, Holbrook TC, Moore B, Taylor DR, Weese JS: Retrospective multicentre study of methicillin-resistant Staphylococcus aureus infections in 115 horses. Equine Vet J; 2009 Apr;41(4):401-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retrospective multicentre study of methicillin-resistant Staphylococcus aureus infections in 115 horses.
  • OBJECTIVES: To provide an overview of the characteristics of clinical MRSA infections in horses.
  • METHODS: A retrospective case study was performed on 115 horses admitted to 6 participating veterinary teaching hospitals in Canada and the United States between 2000 and 2006, and diagnosed with clinical MRSA infection.
  • Descriptive statistics, univariate and multivariable analyses for community- (CA) vs. hospital-associated (HA) MRSA infections, and survival vs. nonsurvival at discharge were performed.
  • HA (58/114, 50.9%) and CA infections (56/114, 49.1%) were equally common.
  • Infection of surgical incisions was most frequently reported (44/115, 38.0%).
  • CONCLUSIONS: Equine MRSA infections have a broad range of clinical presentations, appear to be primarily opportunistic and the overall prognosis for survival to discharge is good.
  • [MeSH-major] Horse Diseases / microbiology. Methicillin-Resistant Staphylococcus aureus. Staphylococcal Infections / veterinary
  • [MeSH-minor] Animals. Community-Acquired Infections / microbiology. Community-Acquired Infections / veterinary. Cross Infection / microbiology. Cross Infection / veterinary. Horses. Retrospective Studies

  • MedlinePlus Health Information. consumer health - MRSA.
  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19562904.001).
  • [ISSN] 0425-1644
  • [Journal-full-title] Equine veterinary journal
  • [ISO-abbreviation] Equine Vet. J.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


5. Pang Y, Zhou Y, Wang S, Song Y, Ou X, Zhao B, Zhang Z, Zhao Y: Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. J Infect; 2015 Aug;71(2):231-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China.
  • OBJECTIVES: Mixed infections have been considered as a potential obstacle for tuberculosis treatment and control.
  • To date, few studies have been done to determine the rate of mixed infections of Mycobacterium tuberculosis in China.
  • RESULTS: Overall, MIRU-VNTR typing identified 115 (3.5%) isolates as being mixed MTBC infections in China.
  • Statistical analysis revealed that mixed infections were significantly more likely to occur in men than women.
  • Compared with the percentage of mixed infection from patients aged 45-56 years, the percentages of mixed infections were higher among patients aged 25-44 years [OR (95% CI): 1.844(1.129-3.014)] and old patients [older than 65 years OR (95% CI): 1.908(1.097-3.319)].
  • In addition, significantly higher frequencies of hemoptysis (P = 0.022) and chest pain (P = 0.012) were observed among mixed infections, using patients infected with a single strain as a reference.
  • CONCLUSIONS: In conclusion, this study has provided the first comprehensive understanding of mixed MTBC infections in China, which will be essential to generate the effective TB control strategies.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2015. Published by Elsevier Ltd.
  • (PMID = 25936744.001).
  • [ISSN] 1532-2742
  • [Journal-full-title] The Journal of infection
  • [ISO-abbreviation] J. Infect.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Keywords] NOTNLM ; China / Mixed infection / Tuberculosis
  •  go-up   go-down


6. Demers AA, Shearer B, Severini A, Lotocki R, Kliewer EV, Stopera S, Wong T, Jayaraman G: Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba. Chronic Dis Inj Can; 2012 Sep;32(4):177-85
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: We conducted a study to investigate the prevalence of human papillomavirus (HPV) infections in an opportunistic sample of women in Manitoba, Canada.
  • We inquired about risk factors associated with HPV infections and linked the HPV typing results with the cervical cancer screening history of the participants.
  • A total of 115 participants (19.4%) had an HPV infection, 89 of whom had a normal Pap test.
  • HPV-16 was the most prevalent type (15/115: 13.0% of infections).
  • [MeSH-major] Alphapapillomavirus. Cervical Intraepithelial Neoplasia / virology. Papillomavirus Infections / epidemiology. Papillomavirus Infections / virology. Uterine Cervical Neoplasms / virology


7. Dhawan B, Malhotra N, Sreenivas V, Rawre J, Khanna N, Chaudhry R, Mittal S: Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections. Indian J Med Res; 2012 Dec;136(6):991-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections.
  • Only a few classes of antimicrobial agents are available for the treatment of mycoplasmal infections in humans.
  • The aim of the present study was to determine the occurrence of Ureaplasma serovars in patients with infertility and genital tract infections with polymerase chain reaction (PCR)-based serotyping.
  • METHODS: Sexually active adults (n=147) with symptoms of genital tract infections and 115 infertile women were enrolled.
  • RESULTS: Ureaplasma was detected in 25.8 per cent patients with genital tract infections and 20.8 per cent in infertile women.
  • INTERPRETATION & CONCLUSIONS: The predominance of Ureaplasma serovar 3/14 suggests their possible pathogenic role in genital tract infections and infertility.
  • [MeSH-major] Anti-Infective Agents / pharmacology. Infertility / microbiology. Reproductive Tract Infections / microbiology. Ureaplasma / drug effects. Ureaplasma / genetics. Ureaplasma Infections / microbiology

  • Genetic Alliance. consumer health - infertility.
  • MedlinePlus Health Information. consumer health - Infertility.
  • Hazardous Substances Data Bank. DOXYCYCLINE .
  • Hazardous Substances Data Bank. Ofloxacin .
  • Hazardous Substances Data Bank. AZITHROMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Antimicrob Chemother. 2000 Apr;45 Suppl 1:29-33 [10824029.001]
  • [Cites] Clin Microbiol Infect. 2010 Nov;16(11):1649-55 [20047607.001]
  • [Cites] Antimicrob Agents Chemother. 2001 Sep;45(9):2604-8 [11502536.001]
  • [Cites] Jpn J Infect Dis. 2004 Feb;57(1):17-20 [14985631.001]
  • [Cites] J Clin Microbiol. 2004 Apr;42(4):1528-33 [15070999.001]
  • [Cites] Antimicrob Agents Chemother. 1986 Feb;29(2):350-2 [3521481.001]
  • [Cites] J Clin Microbiol. 1997 May;35(5):1199-202 [9114407.001]
  • [Cites] J Clin Microbiol. 1998 Oct;36(10):3032-9 [9738062.001]
  • [Cites] J Antimicrob Chemother. 1999 Jun;43 Suppl C:33-6 [10404335.001]
  • [Cites] Clin Microbiol Rev. 2005 Oct;18(4):757-89 [16223956.001]
  • [Cites] Jpn J Infect Dis. 2006 Feb;59(1):57-8 [16495637.001]
  • [Cites] Zhonghua Nan Ke Xue. 2007 Jul;13(7):628-31 [17725308.001]
  • [Cites] Diagn Microbiol Infect Dis. 2008 Jan;60(1):95-7 [17889479.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):641-6 [19130104.001]
  • [Cites] Arch Gynecol Obstet. 2009 Dec;280(6):981-5 [19322575.001]
  • [Cites] Int J Infect Dis. 2010 Feb;14(2):e90-5 [19515594.001]
  • [Cites] J Indian Med Assoc. 2000 Jul;98(7):384-6 [11143859.001]
  • (PMID = 23391795.001).
  • [ISSN] 0971-5916
  • [Journal-full-title] The Indian journal of medical research
  • [ISO-abbreviation] Indian J. Med. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Anti-Infective Agents; 83905-01-5 / Azithromycin; A4P49JAZ9H / Ofloxacin; HV13HFS217 / Josamycin; N12000U13O / Doxycycline
  • [Other-IDs] NLM/ PMC3612329
  •  go-up   go-down


8. Turner S, Kaufman L, Jalbert M: Diagnostic assessment of an enzyme-linked immunosorbent assay for human and canine blastomycosis. J Clin Microbiol; 1986 Feb;23(2):294-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An enzyme-linked immunosorbent assay (ELISA) for blastomycosis was evaluated with 65 human sera from culturally or histologically proven cases of blastomycosis, 53 sera from humans with heterologous infections, and 115 sera from apparently normal people.

  • Genetic Alliance. consumer health - Blastomycosis.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Microbiol. 1973 Sep;26(3):244-7 [4201639.001]
  • [Cites] J Clin Microbiol. 1979 Jul;10(1):1-7 [115894.001]
  • [Cites] J Biol Chem. 1951 Nov;193(1):265-75 [14907713.001]
  • [Cites] Am Rev Respir Dis. 1981 Feb;123(2):209-12 [6786147.001]
  • [Cites] Infect Immun. 1981 Jul;33(1):171-7 [6790440.001]
  • [Cites] Chest. 1980 Jun;77(6):789-95 [7398391.001]
  • (PMID = 2422200.001).
  • [ISSN] 0095-1137
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Antibodies, Fungal; 0 / Antigens, Fungal; 0 / Epitopes
  • [Other-IDs] NLM/ PMC268629
  •  go-up   go-down


9. Zhang XH, Zhang GH, Man CJ, He FM: [Clinical study on the severe hepatitis with nosocomial fungal infections and risk factors]. Zhonghua Gan Zang Bing Za Zhi; 2004 Jul;12(7):389-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical study on the severe hepatitis with nosocomial fungal infections and risk factors].
  • OBJECTIVE: To study the nosocomial fungal infections in the patient with severe hepatitis and analyze of risk factor.
  • METHODS: All 115 severe hepatitis with fungal infections inpatients was studied prospectively.
  • RESULTS: We identified 115 cases with fungal infections, the mean age of patients was 37.2+/-21.5 years, male: 49 cases, female 66 cases.
  • CONCLUSION: Identification of risk factors and predictors of a poor outcome in patients with severe hepatitis with fungal infections, it suggested that implications in prophylaxis of fungal infection, early diagnosis and appropriate therapy would be important for these patients.

  • Genetic Alliance. consumer health - Hepatitis.
  • MedlinePlus Health Information. consumer health - Fungal Infections.
  • MedlinePlus Health Information. consumer health - Yeast Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15268798.001).
  • [ISSN] 1007-3418
  • [Journal-full-title] Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
  • [ISO-abbreviation] Zhonghua Gan Zang Bing Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


10. Hayashi I, Inoue M, Hashimoto H: [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin]. Jpn J Antibiot; 1994 Jun;47(6):595-605
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
  • A clinical investigation on MRSA infections, and the determination of the efficacy and usefulness of arbekacin (ABK) were performed an "MRSA Forum" composed of 18 groups including 115 institutions in Japan.
  • Most of them (94.6%/96.4%) had underlying diseases and they had pneumonia (38/175), sepsis (6/35) or other infections (30/64).
  • Infections by MRSA alone were noted in 41/159 and polymicrobial infections including with MRSA were in 33/115.
  • 53.6%/56.4% of MRSA were eradicated and bacteriological clinical efficacies were 75.6%/67.9% in single infections and 63.6%/71.3% in polymicrobial infections.
  • ABK is effective against MRSA infections.
  • [MeSH-major] Aminoglycosides. Anti-Bacterial Agents. Dibekacin / analogs & derivatives. Methicillin Resistance. Staphylococcal Infections / drug therapy. Staphylococcus aureus / drug effects

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 8072167.001).
  • [ISSN] 0368-2781
  • [Journal-full-title] The Japanese journal of antibiotics
  • [ISO-abbreviation] Jpn J Antibiot
  • [Language] jpn
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Multicenter Study
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Aminoglycosides; 0 / Anti-Bacterial Agents; 45ZFO9E525 / Dibekacin; G7V6SLI20L / habekacin
  •  go-up   go-down


11. Brockmann J, Höhne C: [Use of Vagimid (Metronidazol) for chemotherapy of bacterial genital infections (author's transl)]. Zentralbl Gynakol; 1981;103(1):46-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Use of Vagimid (Metronidazol) for chemotherapy of bacterial genital infections (author's transl)].
  • Vagimid (metronidazol) was used for antibacterial therapy in 115 cases of obstetric or gynaecological infections.
  • The infections were brought under control in all cases.
  • [MeSH-major] Bacterial Infections / drug therapy. Genital Diseases, Female / drug therapy. Metronidazole / therapeutic use

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • Hazardous Substances Data Bank. METRONIDAZOLE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 7223168.001).
  • [ISSN] 0044-4197
  • [Journal-full-title] Zentralblatt für Gynäkologie
  • [ISO-abbreviation] Zentralbl Gynakol
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] GERMANY, EAST
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 140QMO216E / Metronidazole
  •  go-up   go-down


12. Dreizen S, Bodey GP, Valdivieso M: Chemotherapy-associated oral infections in adults with solid tumors. Oral Surg Oral Med Oral Pathol; 1983 Feb;55(2):113-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chemotherapy-associated oral infections in adults with solid tumors.
  • The frequency of chemotherapy-associated oral infections in adult inpatients with solid tumors was determined in 825 subjects with carcinoma, 60 with sarcoma, and 115 with lymphoma.
  • The total number of documented oral infections in the 1,000 patients was 97 (9.7 percent), with frequency rates of 8.4 percent, 11.7 percent, and 18.3 percent for the patients with carcinoma, sarcoma, and lymphoma, respectively.
  • All but six of the infections were caused by a single organism.
  • Microbiologically, 68.9 percent of the infections were ascribable to fungi, 10.7 percent to gram-negative bacilli, 10.7 percent to herpes simplex, and 9.7 percent to gram-positive cocci.
  • The patients with solid tumors were less than one third as prone to oral infections as adults with acute leukemia treated in the same hospital.
  • Among the solid tumor group, those with lymphoma were almost twice as likely to develop infections of the mouth during chemotherapy as those with carcinoma or sarcoma.
  • The oral infection experience in the previously reported patients with acute leukemia and in the present series of patients with solid tumors strongly suggests that the more aggressive the malignancy and the more potent the chemotherapy, the greater the tendency to stomatologic infections.
  • [MeSH-major] Bacterial Infections / etiology. Mouth Diseases / etiology. Mycoses / etiology. Neoplasms / drug therapy


13. Sinha A, Yokoe D, Platt R: Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus. J Pediatr; 2003 May;142(5):492-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus.
  • OBJECTIVES/STUDY DESIGN: Administration of group B streptococcal (GBS) antibiotic prophylaxis to women in labor has dramatically reduced the incidence of GBS neonatal disease, but there is little information on its impact on neonatal infections caused by other organisms.
  • RESULTS: In our study population, 114 of 13,224 infants had 115 non-GBS infections.
  • The incidence of non-GBS neonatal infections fell during the study period, ranging from an attack rate of 9.6 per 1000 infants in 1990 to 1992 to 8.0 per 1000 infants in 1996 to 1998, although this trend was not statistically significant (P >.05).
  • [MeSH-major] Anti-Bacterial Agents / therapeutic use. Antibiotic Prophylaxis. Bacteremia / prevention & control. Infectious Disease Transmission, Vertical / prevention & control. Pregnancy Complications, Infectious / drug therapy. Streptococcal Infections / prevention & control

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Infections and Pregnancy.
  • MedlinePlus Health Information. consumer health - Streptococcal Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12756379.001).
  • [ISSN] 0022-3476
  • [Journal-full-title] The Journal of pediatrics
  • [ISO-abbreviation] J. Pediatr.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / 5 K23 AI01832; United States / AHRQ HHS / HS / U8HS10391; United States / ODCDC CDC HHS / CC / UR8/CCU115079
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  •  go-up   go-down


14. Hayashi I, Inoue M, Hashimoto H: [Questionnaires regarding MRSA in Japan]. Jpn J Antibiot; 1994 Jun;47(6):606-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Changes in properties of MRSA and the status of MRSA infections in the last two years were investigated by an MRSA Forum composed of 18 groups including 115 medical institutions in Japan.
  • Did the pattern of MRSA infections change?
  • 5. How is MRSA related to polymicrobial infections?
  • 6. Is ABK useful against MRSA infections? 7.
  • What will be future trend in characteristics of MRSA and MRSA infections?
  • 2. Severe MRSA infections are decreasing and colonizations are increasing.
  • 5. MRSA infections should be treated with polymicrobial infections in consideration.
  • 6. MRSA did not gain resistance against ABK and ABK is useful against MRSA infections.
  • [MeSH-minor] Dibekacin / analogs & derivatives. Dibekacin / therapeutic use. Humans. Japan. Staphylococcal Infections / drug therapy. Staphylococcal Infections / microbiology. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 8072168.001).
  • [ISSN] 0368-2781
  • [Journal-full-title] The Japanese journal of antibiotics
  • [ISO-abbreviation] Jpn J Antibiot
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Aminoglycosides; 0 / Anti-Bacterial Agents; 45ZFO9E525 / Dibekacin; G7V6SLI20L / habekacin
  •  go-up   go-down


15. Picone S, Aufieri R, Paolillo P: Infection in late preterm infants. Early Hum Dev; 2014 Mar;90 Suppl 1:S71-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Late preterm (LP) are at higher risk than term infants to develop infections due to their more immature immune system.
  • RESULTS: Treated infections were 128, with an incidence of 16.6%; the 90% (n = 115) occurred during the first 72 hours of life.
  • Risk factors for infections were umbilical venous catheter (UVC) insertion (χ(2) = 15.9; p ≤ 0.05), prophylaxis with antenatal corticosteroids (χ(2) = 16.7; p ≤ 0.05) and birth by cesarean section, with observed values very similar to the expected values (χ(2) = 15.9; p = 0.1).
  • Infections, given the high frequency of negative cultures in neonates, should be often suspected and treated on the basis of clinical features and inflammatory markers, trying always to avoid a possible overtreatment.
  • [MeSH-major] Infant, Premature. Sepsis / epidemiology. Staphylococcal Infections / epidemiology

  • MedlinePlus Health Information. consumer health - Premature Babies.
  • MedlinePlus Health Information. consumer health - Sepsis.
  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 24709466.001).
  • [ISSN] 1872-6232
  • [Journal-full-title] Early human development
  • [ISO-abbreviation] Early Hum. Dev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Biomarkers
  • [Keywords] NOTNLM ; Biomarkers / Cultures / Infection / Late preterm / Neonatal sepsis
  •  go-up   go-down


16. Vrljicak K, Milosević D, Batinić D, Kniewald H, Nizić L: The significance of ultrasonography in diagnosing and follow-up of cystic cystitis in children. Coll Antropol; 2006 Jun;30(2):355-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cystic cystitis is a separate form of urinary bladder inflammation, detected by cystoscopy in children with recurrent urinary infections.
  • The study included 115 girls with repeated urinary infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16848151.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


17. Rosner F, Zarrabi MH: Late infections following splenectomy in Hodgkin's disease. Cancer Invest; 1983;1(1):57-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late infections following splenectomy in Hodgkin's disease.
  • Here 145 reported post-splenectomy infections in 115 patients with Hodgkin's disease are reviewed.
  • Such infections can occur at any age (median age 19.8 years) and the interval from splenectomy to the infection is quite variable (median 21.9 months).
  • Most infections are present clinically as pneumonia, septicemia, meningitis, or a combination thereof, with the most common offending organism being pneumococcus.
  • Prophylactic penicillin should be administered at least for 3 years and possibly indefinitely since post-splenectomy infections can occur many years later.
  • [MeSH-major] Bacterial Infections / etiology. Hodgkin Disease / complications. Splenectomy / adverse effects

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 6667400.001).
  • [ISSN] 0735-7907
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Penicillins
  •  go-up   go-down


18. Laban KG, Rinkel GJ, Vergouwen MD: Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens. Int J Stroke; 2015 Jul;10(5):763-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens.
  • BACKGROUND: Nosocomial infections after aneurysmal subarachnoid hemorrhage (aSAH) are associated with prolonged length of stay and poor functional outcome.
  • It remains unclear if infections result in prolonged length of stay or, vice versa, if prolonged length of stay results in more infections.
  • Before strategies can be designed to reduce infections after aneurysmal subarachnoid hemorrhage, more data are needed on time course and causative pathogens of infections.
  • AIM: To investigate the time course of infection onset and bacterial microorganisms that cause nosocomial infections after aSAH.
  • METHODS: In consecutive patients with aneurysmal subarachnoid hemorrhage admitted to the University Medical Center Utrecht between 2009 and 2011, we analyzed the proportion of patients with infections, day of infection onset, and culture results.
  • RESULTS: Of the 291 included patients, 107 (37%) patients developed 115 nosocomial infections.
  • Cultures of infections mostly yielded Staphylococcus aureus (20%), Haemophilus influenzae (15%), and Escherichia coli (14%), CONCLUSION: Nosocomial infections after subarachnoid hemorrhage are common and mostly occur in the first week after ictus.
  • Future studies should investigate if general hygienic measures, infection awareness, minimizing the duration of mechanical ventilation and use of catheters/drains, or prophylactic antibiotics reduce infections and improve functional outcome.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2015 World Stroke Organization.
  • (PMID = 25900178.001).
  • [ISSN] 1747-4949
  • [Journal-full-title] International journal of stroke : official journal of the International Stroke Society
  • [ISO-abbreviation] Int J Stroke
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; aneurysm / infection / meningitis / pneumonia / subarachnoid hemorrhage / urinary tract infection
  •  go-up   go-down


19. Safronova ON, Nedel'skaia SN, Boiarskaia LN, Raspopina VI: [Clinico-laboratory criteria in the diagnosis of ARVI and respiratory allergoses in children]. Pediatriia; 1991;(8):19-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 115 patients with allergoses and 104 patients suffering from acute respiratory viral infections (ARVI).
  • [MeSH-major] Respiratory Hypersensitivity / diagnosis. Respiratory Tract Infections / diagnosis. Virus Diseases / diagnosis

  • MedlinePlus Health Information. consumer health - Viral Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1762851.001).
  • [ISSN] 0031-403X
  • [Journal-full-title] Pediatrii︠a︡
  • [ISO-abbreviation] Pediatriia
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] USSR
  • [Chemical-registry-number] 0 / Antibodies, Viral
  •  go-up   go-down


20. González-Hevia MA, Alvarez JA, Mendoza MC: [Salmonella enterica in the Avilés health district (Asturias). Microbiological, clinical, and epidemiological aspects]. Enferm Infecc Microbiol Clin; 1990 Mar;8(3):144-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The results of the follow up of the Salmonella enterica infections seen in the Hospital San Agustin in Avilés (Asturias) from 1984 through 1987 are reported.
  • 326 patients were involved: acute gastroenteritis (314 cases, with bacteremia in 10), typhoid fever (7 cases) and other infections (5 cases); 172 patients required hospital attention and 115 antimicrobial therapy.
  • [MeSH-major] Salmonella Infections / epidemiology

  • MedlinePlus Health Information. consumer health - Salmonella Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 2094387.001).
  • [ISSN] 0213-005X
  • [Journal-full-title] Enfermedades infecciosas y microbiología clínica
  • [ISO-abbreviation] Enferm. Infecc. Microbiol. Clin.
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] SPAIN
  •  go-up   go-down


21. Chikviladze DP, Metreveli DA, Gachechiladze KhE, Mikeladze ML: [Antibiotic resistance of nosocomial strains of Staphylococcus spicies]. Georgian Med News; 2012 Jan;(202):60-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 115 clinical strains of Staphylococcus spicies were isolated in 2005-2010 and investigated from patients with wound infections hospitalized in Tbilisi surgical clinics.

  • MedlinePlus Health Information. consumer health - MRSA.
  • Hazardous Substances Data Bank. METHICILLIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22392785.001).
  • [ISSN] 1512-0112
  • [Journal-full-title] Georgian medical news
  • [ISO-abbreviation] Georgian Med News
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Georgia (Republic)
  • [Chemical-registry-number] Q91FH1328A / Methicillin
  •  go-up   go-down


22. Kopp SL, Berbari EF, Osmon DR, Schroeder DR, Hebl JR, Horlocker TT, Hanssen AD: The Impact of Anesthetic Management on Surgical Site Infections in Patients Undergoing Total Knee or Total Hip Arthroplasty. Anesth Analg; 2015 Nov;121(5):1215-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Impact of Anesthetic Management on Surgical Site Infections in Patients Undergoing Total Knee or Total Hip Arthroplasty.
  • Our secondary aim was to determine which patient, anesthetic, and surgical variables influence the risk of SSI.
  • The cases were matched 1:2 with controls based on type of joint replacement (TKA versus THA), type of procedure (primary, bilateral, revision), sex, date of surgery (within 1 year), ASA physical status (I and II versus III, IV, and V), and operative time (<3 vs >3 hours).
  • Of the infections identified, 115 (57%) occurred within the first 30 days and 87 (43%) occurred between 31 and 365 days.

  • MedlinePlus Health Information. consumer health - Hip Replacement.
  • MedlinePlus Health Information. consumer health - Knee Replacement.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 26484458.001).
  • [ISSN] 1526-7598
  • [Journal-full-title] Anesthesia and analgesia
  • [ISO-abbreviation] Anesth. Analg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


23. Oberender H, Graessner U, Falkenhagen U, Kunkel M, Gärtner L, Kupatz H, Schumacher K: Epstein-Barr virus infections in childhood. Acta Virol; 1979 Mar;23(2):137-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epstein-Barr virus infections in childhood.
  • IgM and IgG antibodies against Epstein-Barr virus (EBV) capsid antigen and antibodies against EBV nuclear antigen and heterophil antibodies were investigated in 115 paired sera of children with acute infections and in 100 sera of healthy controls of the same age and sex.
  • [MeSH-major] Antibodies, Viral / analysis. Herpesvirus 4, Human / immunology. Infectious Mononucleosis / immunology. Respiratory Tract Infections / immunology

  • MedlinePlus Health Information. consumer health - Infectious Mononucleosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 39436.001).
  • [ISSN] 0001-723X
  • [Journal-full-title] Acta virologica
  • [ISO-abbreviation] Acta Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] CZECHOSLOVAKIA
  • [Chemical-registry-number] 0 / Antibodies, Heterophile; 0 / Antibodies, Viral; 0 / Antigens, Viral; 0 / Immunoglobulin G; 0 / Immunoglobulin M
  •  go-up   go-down


24. Aboulafia DM, Mitsuyasu RT, Slamon DJ: Human T-cell leukemia virus infection in non-intravenous drug using HIV seropositive men in Los Angeles. AIDS Res Hum Retroviruses; 1991 Mar;7(3):333-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • HIV-infected groups were comprised of asymptomatic homosexuals (n = 131), AIDS-related complex (n = 115), Kaposi's sarcoma (n = 300), AIDS-defining opportunistic infections (n = 76), and high-grade lymphomas (n = 12).
  • [MeSH-major] Deltaretrovirus Infections / complications. HIV Seropositivity / complications

  • Genetic Alliance. consumer health - HIV.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1676593.001).
  • [ISSN] 0889-2229
  • [Journal-full-title] AIDS research and human retroviruses
  • [ISO-abbreviation] AIDS Res. Hum. Retroviruses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


25. Mohamed NH, Salem SA, Azab ME, Bebars MA, Khattab HM, Kamal AM, Mohamed MS: Parasitic infections associated with mental retardation in Egypt. J Egypt Soc Parasitol; 1991 Aug;21(2):319-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parasitic infections associated with mental retardation in Egypt.
  • Examination of 150 mentally retarded patients for parasitic infections by urine and stool analysis revealed that 115 (76.67%) were positive.

  • Genetic Alliance. consumer health - Mental Retardation.
  • MedlinePlus Health Information. consumer health - Parasitic Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1875063.001).
  • [ISSN] 1110-0583
  • [Journal-full-title] Journal of the Egyptian Society of Parasitology
  • [ISO-abbreviation] J Egypt Soc Parasitol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] EGYPT
  •  go-up   go-down


26. Chen SL, Zhao HR, Zhang YQ, Zhao CY, Li BJ, Bai GY, Liang L, Chen ZQ, Hui YL, Wang W, Lu XL: [A retrospective cohort study on the natural history of AIDS caused by blood transfusion]. Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul;33(7):658-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: All HIV infections and AIDS patients were from Hebei province, including those infected through blood transfusion around 1995, that were identified as through general census of former commercial plasma donors (FCPDs).
  • Among those objects being observed during the incubation period, 354 had HIV infections (including 142 cases infected via plasmapheresis and 212 cases caused by transfusion) but had not been treated by HAART before the onset of disease.
  • RESULTS: By December 31, 2010, the cumulative incidence among HIV infections was 88.70% (314/354), with the incidence density as 9.14/100 person-years (314/3435.75) and the median incubation period was 113 months.
  • Of 142 HIV infections in the blood donation group and 212 infections in the blood transfusion group, the incubation periods were 112 months and 115 months, respectively.
  • Among those 57 FCPDs infections, they were all died 24 months after the onset, with the death-strength as 250.66/100 person-years (57/22.74) and the survival was 3 months.
  • The other 84 infections who were blood recipients, all died 34 months after the onset, with the death-strength as 182.05/100 person-years (84/ 46.14) and the survival was 4 months.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / etiology. Blood Donors. Blood Transfusion / adverse effects. HIV Infections / epidemiology

  • Genetic Alliance. consumer health - AIDS-HIV.
  • MedlinePlus Health Information. consumer health - Blood Transfusion and Donation.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22968011.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


27. Hamedani P, Hafeez S, Ali J, Memon R, Ali S, Ali M, Ansari M, Raza R: Acute and chronic Legionnaires' disease and co-existent tuberculosis: a trial of erythromycin. Curr Med Res Opin; 1989;11(8):510-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To assess the prevalence of Legionnaires' disease, 115 patients with 'difficult-to-treat' chest infections were screened for Legionnella pneumophila.
  • It is suggested that the possibility of co-existing legionellosis should be considered in all patients with difficult to treat acute and chronic chest infections, particularly in developing countries where tuberculosis is very common, and treatment instituted or supplemented with erythromycin as the drug of choice.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Legionnaires' Disease.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Erythromycin .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 2680287.001).
  • [ISSN] 0300-7995
  • [Journal-full-title] Current medical research and opinion
  • [ISO-abbreviation] Curr Med Res Opin
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 63937KV33D / Erythromycin
  •  go-up   go-down


28. Langdon PC, Lee AH, Binns CW: High incidence of respiratory infections in 'nil by mouth' tube-fed acute ischemic stroke patients. Neuroepidemiology; 2009;32(2):107-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High incidence of respiratory infections in 'nil by mouth' tube-fed acute ischemic stroke patients.
  • BACKGROUND: Respiratory infections are common in acute stroke.
  • Previous studies have found dysphagia is associated with respiratory infections.
  • Of interest is whether patients who are 'Nil by Mouth' (NBM) and tube fed have higher risk of developing infections due to aspiration of bacteria-laden saliva or refluxed material than stroke patients who are fed orally.
  • METHODS: Prospective cohort of 330 ischemic stroke survivors were followed for 30 days and infections recorded.
  • RESULTS: 115 infections were treated with antibiotics; these included 51 respiratory infections.
  • Incidence of infection in NBM tube-fed stroke patients (n = 74) was 69%, with 30 respiratory infections occurring in 74 patients who received enteral feeding after stroke.
  • We also saw a significant time-to-event effect with 73% (22/30) respiratory infections in tube-fed survivors diagnosed on days 2-4 after stroke, and 76% (39/51) of infections in all tube-fed survivors occurring by day 7 after stroke.
  • CONCLUSIONS: NBM tube-fed survivors were unlikely to have aspirated anything other than saliva/secretions or reflux, yet experienced significantly higher rates of respiratory infections than survivors fed orally.
  • [MeSH-major] Brain Ischemia / epidemiology. Enteral Nutrition / adverse effects. Respiratory Tract Infections / epidemiology. Respiratory Tract Infections / etiology. Stroke / epidemiology

  • Genetic Alliance. consumer health - Ischemic stroke.
  • MedlinePlus Health Information. consumer health - Ischemic Stroke.
  • MedlinePlus Health Information. consumer health - Stroke.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2008 S. Karger AG, Basel.
  • (PMID = 19039243.001).
  • [ISSN] 1423-0208
  • [Journal-full-title] Neuroepidemiology
  • [ISO-abbreviation] Neuroepidemiology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  •  go-up   go-down


29. Calame A, Fawer CL, Anderegg A, Perentes E: Interaction between perinatal brain damage and processes of normal brain development. Ultrasonographic and neurodevelopmental study in the first year of life. Dev Neurosci; 1985;7(1):1-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In group B (115 neonates of more than 34 weeks gestation), miscellaneous ultrasound changes were observed (malformations, infections, hemorrhages and hypoxic-ischemic lesions).
  • Malformations, hypoxic-ischemic damage and prenatal infections had a gloomy prognosis.

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • MedlinePlus Health Information. consumer health - Premature Babies.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3896746.001).
  • [ISSN] 0378-5866
  • [Journal-full-title] Developmental neuroscience
  • [ISO-abbreviation] Dev. Neurosci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] SWITZERLAND
  •  go-up   go-down


30. Howell LP, Davis RL, Belk TI, Agdigos R, Lowe J: The AutoCyte preparation system for gynecologic cytology. Acta Cytol; 1998 Jan-Feb;42(1):171-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CytoRich detected more infections (151 vs. 115) and had 66% fewer nonspecific inflammatory diagnoses.
  • CONCLUSION: CytoRich preps improve adequacy; increase detection of infections, such as candidiasis and trichomoniasis; and are accurate in the diagnosis of SILs.


31. Dzik JM, Dobrzańska A, Gruszfeld D, Walajtys-Rode E: Nitric oxide metabolites in the urine of full-term and preterm infants. Pediatr Int; 2002 Aug;44(4):368-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Low NOx (115 nmol/mL) levels accompanied generalized infections, while its high contents (650 nmol/mL) was found in cytomegalovirus and one case of Pneumocystis carinii infection.
  • Moderate increase of NOx production was observed in infants with local pulmonary infections and encephalopathies.

  • MedlinePlus Health Information. consumer health - Premature Babies.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12139559.001).
  • [ISSN] 1328-8067
  • [Journal-full-title] Pediatrics international : official journal of the Japan Pediatric Society
  • [ISO-abbreviation] Pediatr Int
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Nitrates; 0 / Nitrites; 31C4KY9ESH / Nitric Oxide
  •  go-up   go-down


32. Ochirkhuu N, Konnai S, Mingala CN, Okagawa T, Villanueva M, Pilapil FM, Murata S, Ohashi K: Molecular epidemiological survey and genetic analysis of vector-borne infections of cattle in Luzon Island, the Philippines. Vet Parasitol; 2015 Sep 15;212(3-4):161-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular epidemiological survey and genetic analysis of vector-borne infections of cattle in Luzon Island, the Philippines.
  • Out of the 339 samples, 324 (95.5%), 154 (45.4%), 209 (61.6%), 140 (41.3%), and 2 (0.6%) were positive for Anaplasma marginale, Babesia bigemina, Babesia bovis, Theileria spp., and Trypanosoma evansi infections, respectively.
  • Mixed infections were detected in 290 (85.5%) samples, of which 115 (33.9%) had two pathogens, 144 (42.5%) had three pathogens, and 31 (9.1%) had four kinds of pathogens.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2015 Elsevier B.V. All rights reserved.
  • (PMID = 26138152.001).
  • [ISSN] 1873-2550
  • [Journal-full-title] Veterinary parasitology
  • [ISO-abbreviation] Vet. Parasitol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Amarginale / B. bigemina / B. bovis / Philippines / T. evansi / Theileria
  •  go-up   go-down


33. Tyutyunnik VL, Kan NE, Lomova NA, Karapetyan TE, Kogan EA, Shchyogolev AI: Role of innate immunity in pregnant patients with vulvovaginal infections in the development of intrauterine infection in the newborn. Bull Exp Biol Med; 2014 Nov;158(1):74-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of innate immunity in pregnant patients with vulvovaginal infections in the development of intrauterine infection in the newborn.
  • A total of 115 pregnant women were examined: 59 patients with opportunistic vulvovaginal infections and 56 without infection.


34. Wagner MB, Petrillo V, Gay V, Fagundes GR: A prevalence survey of nosocomial infection in a Brazilian hospital. J Hosp Infect; 1990 May;15(4):379-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of 397 patients surveyed, infections were present in 168 (42.3%); 53 (13.4%) were hospital acquired and 115 (29%) community acquired.
  • The commonest infections involved the lower respiratory tract (30%), bacteraemias (24.4%) and the urinary tract (10%).
  • [MeSH-minor] Bacterial Infections / epidemiology. Brazil / epidemiology. Cross-Sectional Studies. Epidemiologic Methods. Humans. Respiratory Tract Infections / epidemiology. Urinary Tract Infections / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1972954.001).
  • [ISSN] 0195-6701
  • [Journal-full-title] The Journal of hospital infection
  • [ISO-abbreviation] J. Hosp. Infect.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] ENGLAND
  •  go-up   go-down


35. Audebert AJ: [Use of Polygynax in pregnant women for preventing cervico-vaginal infections]. Rev Fr Gynecol Obstet; 1989 Mar 25;84(3 Pt 2):287-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Use of Polygynax in pregnant women for preventing cervico-vaginal infections].
  • [Transliterated title] Utilisation de Polygynax chez la femme enceinte en prévention des infections cervico-vaginales.
  • 115 women, distributed in 20 centres, were included in a randomized study designed to assess the efficacy of Polygynax in preventing vaginal infections in women at risk, at the start of pregnancy.
  • [MeSH-major] Arsenicals / therapeutic use. Bacterial Infections / prevention & control. Neomycin / therapeutic use. Nystatin / therapeutic use. Polymyxins / therapeutic use. Pregnancy Complications, Infectious / prevention & control. Uterine Cervical Diseases / prevention & control. Vaginal Diseases / prevention & control

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Cervix Disorders.
  • MedlinePlus Health Information. consumer health - Infections and Pregnancy.
  • MedlinePlus Health Information. consumer health - Vaginal Diseases.
  • Hazardous Substances Data Bank. NYSTATIN .
  • Hazardous Substances Data Bank. NEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 2555894.001).
  • [ISSN] 0035-290X
  • [Journal-full-title] Revue française de gynécologie et d'obstétrique
  • [ISO-abbreviation] Rev Fr Gynecol Obstet
  • [Language] fre
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial
  • [Publication-country] FRANCE
  • [Chemical-registry-number] 0 / Arsenicals; 0 / Drug Combinations; 0 / Polymyxins; 1400-61-9 / Nystatin; 1404-04-2 / Neomycin; 78891-94-8 / acetarsol, dimethicone, neomycin, nystatin, polymyxin drug combination
  •  go-up   go-down


36. Trisler Z, Seme K, Poljak M, Celan-Lucu B, Sakoman S: Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scand J Infect Dis; 1999;31(1):33-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia.
  • The prevalence of hepatitis C virus (HCV) and hepatitis G virus (HGV) infections was assessed in 115 Slovenian and 102 Croatian intravenous drug users (IVDUs).
  • HCV and HGV infections were detected in 60 (52.2%) and 61 (53.0%) Slovenian IVDUs and in 70 (68.6%) and 39 (38.2%) Croatian IVDUs, respectively.

  • Genetic Alliance. consumer health - Hepatitis.
  • MedlinePlus Health Information. consumer health - Hepatitis C.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10381215.001).
  • [ISSN] 0036-5548
  • [Journal-full-title] Scandinavian journal of infectious diseases
  • [ISO-abbreviation] Scand. J. Infect. Dis.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] SWEDEN
  • [Chemical-registry-number] 0 / Antibodies, Viral; 0 / RNA, Viral
  •  go-up   go-down


37. Scott ME, Gibbs HC: Long-term population dynamics of pinworms (Syphacia obvelata and Aspiculuris tetraptera) in mice. J Parasitol; 1986 Oct;72(5):652-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The population dynamics of concurrent infections of Syphacia obvelata and Aspiculuris tetraptera (Nematoda) in laboratory mice were investigated under conditions of constant re-exposure over periods of 56 and 115 days.
  • [MeSH-major] Nematoda / growth & development. Nematode Infections / parasitology. Oxyuriasis / parasitology. Oxyuroidea / growth & development
  • [MeSH-minor] Animals. Female. Host-Parasite Interactions. Mice. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3806316.001).
  • [ISSN] 0022-3395
  • [Journal-full-title] The Journal of parasitology
  • [ISO-abbreviation] J. Parasitol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] UNITED STATES
  •  go-up   go-down


38. Parekh BS, Hu DJ, Vanichseni S, Satten GA, Candal D, Young NL, Kitayaporn D, Srisuwanvilai LO, Rakhtam S, Janssen R, Choopanya K, Mastro TD: Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Res Hum Retroviruses; 2001 Mar 20;17(5):453-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To evaluate this approach in non-B subtypes, longitudinal specimens (n = 522) collected from 90 incident infections among injecting drug users in Bangkok (subtype B infection, n = 18; subtype E infection, n = 72) were tested by the 3A11-LS assay.
  • About 4% of individuals with incident subtype E infections remained below the threshold (SOD of 0.75), even 2 years after seroconversion.
  • Among the patients with clinical AIDS and declining antibodies, none of the 7 individuals with subtype B, but 10 (8.7%) of 115 with subtype E infections, were misclassified as recent infections.
  • Our results demonstrate that the 3A11-LS assay has different performance characteristics in detecting recent infections among individuals infected with subtypes B or E.
  • [MeSH-major] Algorithms. HIV Infections / immunology. HIV Seropositivity / diagnosis. HIV-1 / classification. Immunoassay
  • [MeSH-minor] Adult. Humans. Immunophenotyping. Longitudinal Studies. Male. Sensitivity and Specificity. Substance Abuse, Intravenous / complications. Thailand. Time Factors

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11282014.001).
  • [ISSN] 0889-2229
  • [Journal-full-title] AIDS research and human retroviruses
  • [ISO-abbreviation] AIDS Res. Hum. Retroviruses
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Ogunro PS, Adeneye AK, Ogungbamigbe TO, Adewole TA, Musa AZ, Isikwei JI: Perceptions of the benefits and affordability of antiretrovirals among HIV-positive persons in a rural area of South-West Nigeria. Afr J AIDS Res; 2006 Nov;5(3):233-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To assess the affordability of antiretroviral drugs (ARVs) and accessibility to treatment for opportunistic infections (OIs) among HIV-1 seropositive persons, we used semi-structured interviewer-administered questionnaires to interview 154 individuals seeking ARV treatment at the Daughter of Charity German Leprosy and Tuberculosis Centre in South-West Nigeria.
  • Thirty-nine respondents (25.3%) had symptomatic AIDS with evidence of opportunistic infections (OIs), and 115 (74.7%) were HIV-1 seropositive only.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25865913.001).
  • [ISSN] 1608-5906
  • [Journal-full-title] African journal of AIDS research : AJAR
  • [ISO-abbreviation] Afr J AIDS Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] South Africa
  • [Keywords] NOTNLM ; ACCESS TO THERAPY / AFRICA / NATIONAL AIDS PROGRAMMES / PERCEPTION / PROGRAMME PLANNING / TREATMENT COST
  •  go-up   go-down


40. Dubey JP, Livingston CW Jr: Sarcocystis capracanis and Toxoplasma gondii infections in range goats from Texas. Am J Vet Res; 1986 Mar;47(3):523-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcocystis capracanis and Toxoplasma gondii infections in range goats from Texas.
  • Specimens of tongues, esophagi, diaphragms, or abdominal muscles of 115 range goats from San Angelo, Tex, were examined for Sarcocystis and Toxoplasma gondii infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3083732.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


41. Shibasaki M, Komatsu M, Sueyoshi N, Maeda M, Uchida T, Yonezawa H, Inagaki K, Omi A, Matsumoto H, Murotani M, Iwamoto T, Kodaka Y, Kieda H, Tokiwa M, Masuwa B, Kinoshita M, Saito K, Katou M: Community spread of extended-spectrum β-lactamase-producing bacteria detected in social insurance hospitals throughout Japan. J Infect Chemother; 2016 Jun;22(6):395-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We surveyed the status of community-acquired infections involving four extended-spectrum β-lactamase (ESBL)-producing bacteria (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis) isolated from clinical specimens from 11 social insurance hospitals in Japan in 2012.
  • ESBL-producing bacteria isolation rates in each hospital ranged from 5.8% to 21.5% (median 9.5%), and the proportion of community-acquired infections among ESBL-producing bacteria isolates ranged from 1.6% to 30.8% (median 11.4%) in each hospital.
  • Overall, the rates of ESBL-producing bacterial infection in all community-acquired infections and in all hospital infections were 10.6% (115/1081) and 10.7% (87/812), respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 27066881.001).
  • [ISSN] 1437-7780
  • [Journal-full-title] Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • [ISO-abbreviation] J. Infect. Chemother.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; ESBL / Enterobacteriaceae / PCR / Surveillance
  •  go-up   go-down


42. Isomäki O, Vuento R, Granfors K: Serological diagnosis of salmonella infections by enzyme immunoassay. Lancet; 1989 Jun 24;1(8652):1411-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serological diagnosis of salmonella infections by enzyme immunoassay.
  • Of 130 sera from patients with culture-confirmed salmonella infections, 115 (88.5%) were positive in this assay.
  • This EIA method offers a substantial advance in the serological diagnosis of acute salmonella infections; it detects antibodies to the salmonellae of groups B and D, which constitute about 70% of culture-positive cases of human salmonellosis.
  • [MeSH-major] Antibodies, Bacterial / analysis. Immunoglobulin A / analysis. Immunoglobulin G / analysis. Immunoglobulin M / analysis. Salmonella / immunology. Salmonella Infections / immunology

  • MedlinePlus Health Information. consumer health - Salmonella Infections.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Lancet. 1989 Aug 19;2(8660):456 [2569643.001]
  • (PMID = 2567429.001).
  • [ISSN] 0140-6736
  • [Journal-full-title] Lancet (London, England)
  • [ISO-abbreviation] Lancet
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Immunoglobulin A; 0 / Immunoglobulin G; 0 / Immunoglobulin M
  •  go-up   go-down


43. Flórez AC, García DA, Moncada L, Beltrán M: [Prevalence of microsporidia and other intestinal parasites in patients with HIV infection, Bogota, 2001]. Biomedica; 2003 Sep;23(3):274-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To determine the prevalence of microsporidia and other opportunistic parasites infecting HIV patients in Bogotá, Colombia, 115 patients were examined for these infections during the year 2001.
  • The average patient age was 36 years, with a range from 18 to 71 years.
  • [MeSH-major] AIDS-Related Opportunistic Infections / epidemiology. AIDS-Related Opportunistic Infections / parasitology. Intestinal Diseases, Parasitic / epidemiology. Microsporidiosis / epidemiology

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS and Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14582330.001).
  • [ISSN] 0120-4157
  • [Journal-full-title] Biomédica : revista del Instituto Nacional de Salud
  • [ISO-abbreviation] Biomedica
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Colombia
  •  go-up   go-down


44. Wang HY, Kim J, Kim S, Park SD, Kim HY, Choi HK, Uh Y, Lee H: Performance of PCR-REBA assay for screening and identifying pathogens directly in whole blood of patients with suspected sepsis. J Appl Microbiol; 2015 Nov;119(5):1433-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: Rapid and accurate identification of a broad range of bacterial and fungal pathogens is the key to successful management of patients with bloodstream infections (BSIs).
  • Of 115 patients with positive blood culture, 64 (55·7%) were Gram-positive bacteria, 35 (30·4%) were Gram-negative bacteria, 1 (0·9%) was Candida albicans and 15 (13·0%) were polymicrobial infections.

  • MedlinePlus Health Information. consumer health - Sepsis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2015 The Society for Applied Microbiology.
  • (PMID = 26299262.001).
  • [ISSN] 1365-2672
  • [Journal-full-title] Journal of applied microbiology
  • [ISO-abbreviation] J. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  • [Keywords] NOTNLM ; PCR-REBA / blood culture / molecular diagnosis / sepsis / whole blood
  •  go-up   go-down


45. Advani SH, Kochupillai V, Lalitha N, Shanta V, Maitreyan V, Nair R, Banerjee U, Kelkar R, Mukherjee S: Infections in the immunocompromised host: a prospective multicenter survey in patients receiving chemotherapy for acute leukemia. J Assoc Physicians India; 1996 Nov;44(11):769-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infections in the immunocompromised host: a prospective multicenter survey in patients receiving chemotherapy for acute leukemia.
  • Of these, 490 cycles were received by patients with acute lymphoblastic leukemia (ALL) and 115 by patients with acute non-lymphoblastic leukemia (ANLL).
  • Infections were more common during chemotherapy for ANLL than for ALL, occurring in 54% (62/115) and 36% (179/490) of chemotherapeutic cycle respectively.
  • [MeSH-major] Immunocompromised Host. Leukemia, Myeloid, Acute / drug therapy. Opportunistic Infections. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9251449.001).
  • [ISSN] 0004-5772
  • [Journal-full-title] The Journal of the Association of Physicians of India
  • [ISO-abbreviation] J Assoc Physicians India
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] INDIA
  •  go-up   go-down


46. Meloni F, Paschetto E, Mangiarotti P, Crepaldi M, Morosini M, Bulgheroni A, Fietta A: Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother; 2004 Feb;16(1):70-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
  • Rates of acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections were determined in 115 adults hospitalized for community-acquired pneumonia (CAP), purulent exacerbations of COPD and acute exacerbations of bronchial asthma, by means of serology and molecular methods.
  • These findings highlight the importance of taking into account C. pneumoniae and M. pneumoniae infections in guiding the choice of empirical antibacterial treatment for CAP and purulent exacerbations of COPD.
  • [MeSH-major] Asthma / complications. Chlamydophila Infections / drug therapy. Chlamydophila Infections / etiology. Chlamydophila pneumoniae / pathogenicity. Mycoplasma pneumoniae / pathogenicity. Pneumonia, Bacterial / drug therapy. Pneumonia, Bacterial / etiology. Pneumonia, Mycoplasma / drug therapy. Pneumonia, Mycoplasma / etiology. Pulmonary Disease, Chronic Obstructive / complications
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Aged. Aged, 80 and over. Case-Control Studies. Community-Acquired Infections. Female. Humans. Male. Middle Aged. Seroepidemiologic Studies


47. Graber HU, Pfister S, Burgener P, Boss R, Meylan M, Hummerjohann J: Bovine Staphylococcus aureus: diagnostic properties of specific media. Res Vet Sci; 2013 Aug;95(1):38-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Various media and the coagulase tube test were investigated using 116 strains of S. aureus and 115 of NSA, all isolated from cows with spontaneous intramammary infections (IMI).
  • [MeSH-major] Mastitis, Bovine / microbiology. Staphylococcal Infections / veterinary. Staphylococcus aureus / isolation & purification

  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 Elsevier Ltd. All rights reserved.
  • (PMID = 23548479.001).
  • [ISSN] 1532-2661
  • [Journal-full-title] Research in veterinary science
  • [ISO-abbreviation] Res. Vet. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Culture Media; 0 / DNA, Bacterial
  •  go-up   go-down


48. Wang N, Zhao JW, Xu CY: [A study on serotypes of U. urealyticum isolated from different populations]. Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug;16(4):207-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is a study on serotypes 1-14 Ureaplasma urealyticum (Uu) infections of genitourinary in different populations.
  • The results show that 1) the Uu infection rate is the highest in sexually promiscuous persons with STDs (78/115, 67.83%), lesser in both sexually promiscuous persons without STDs (97/185, 52.43%) and in general population with common genitourinary infections (84/180, 46.67%), and the lowest in healthy controls (73/320, 22.81%);.
  • 2) all of the 14 serotypes and untypeable Uu infections existed in China are identified;.
  • 3) the relationship between Uu 1 and 4 serotype and infections is stronger, but medium strong in 2, 8 and 10 serotype, whereas, 3, 9 and 14 serotype are major colonizational strains;.
  • 4) multi-serotypes infections are closely associated with sexually promiscuous behaviour.
  • [MeSH-major] Sexually Transmitted Diseases, Bacterial / microbiology. Ureaplasma Infections. Ureaplasma urealyticum / isolation & purification. Urinary Tract Infections / microbiology. Vaginitis / microbiology

  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 7585898.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] CHINA
  •  go-up   go-down


49. Basco LK, Ringwald P: Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients. Am J Trop Med Hyg; 2001 Dec;65(6):798-803
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients.
  • Of the total of 177 DNA samples analyzed (of which 115 were paired pre- and posttreatment samples), 101 (57%) were composed of multiclonal infections, with up to 7 distinguishable parasite populations.
  • Patients with multiclonal infections before treatment had, on average, 2.9 genetically distinct parasite populations.
  • Further studies in different epidemiological settings are required to understand the role of multiclonal Plasmodium falciparum infections in influencing malaria transmission.

  • Genetic Alliance. consumer health - Malaria.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11791977.001).
  • [ISSN] 0002-9637
  • [Journal-full-title] The American journal of tropical medicine and hygiene
  • [ISO-abbreviation] Am. J. Trop. Med. Hyg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimalarials; 0 / DNA Primers; 0 / DNA, Protozoan
  •  go-up   go-down


50. Wölbling RH, Leonhardt K: Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine; 1994 Jun;1(1):25-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An overt multicentric study involving 115 patients and another subsequent placebo-controlled double-blind study involving 116 patients contributed significantly to the corroborative evidence of the antiviral activity in vitro of a specially prepared dried extract from Melissa leaves (Melissa officinalis L.) against herpes simplex infections.
  • The studies provided the proof that the ingredient gave protection against herpes simplex infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 1994 Gustav Fischer Verlag, Stuttgart · Jena · New York. Published by Elsevier GmbH.. All rights reserved.
  • (PMID = 23195812.001).
  • [ISSN] 0944-7113
  • [Journal-full-title] Phytomedicine : international journal of phytotherapy and phytopharmacology
  • [ISO-abbreviation] Phytomedicine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


51. Patel N, Nair SU, Gowd P, Gupta A, Morris D, Geronilla GG, Lundbye J: Central line associated blood stream infection related to cooling catheter in cardiac arrest survivors undergoing therapeutic hypothermia by endovascular cooling. Conn Med; 2013 Jan;77(1):35-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: The risk of central line associated blood stream infections (CLABSI) related to cooling catheters used for therapeutic hypothermia (TH) is unclear.
  • Cooling catheter related CLABSI and other infections over a period of seven days from initiation of TH were estimated.
  • Of the remaining 115 (88%) patients, zero (0%) patients had cooling catheter related CLABSI and 23 (20%) patients had other infections during the study period.
  • [MeSH-major] Catheter-Related Infections / etiology. Catheterization, Central Venous / adverse effects. Cross Infection / etiology. Heart Arrest / therapy. Hypothermia, Induced / methods. Sepsis / etiology

  • MedlinePlus Health Information. consumer health - Cardiac Arrest.
  • MedlinePlus Health Information. consumer health - Sepsis.
  • Hazardous Substances Data Bank. AMPICILLIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23427372.001).
  • [ISSN] 0010-6178
  • [Journal-full-title] Connecticut medicine
  • [ISO-abbreviation] Conn Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 65DT0ML581 / sultamicillin; 7C782967RD / Ampicillin; S4TF6I2330 / Sulbactam
  •  go-up   go-down


52. GAON J, TERZIN AL: Some viral and rickettsial infections in Bosnia and Herzegovina; a sero-epidemiological study. Bull World Health Organ; 1956;15(1-2):299-316
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Some viral and rickettsial infections in Bosnia and Herzegovina; a sero-epidemiological study.
  • Investigating viral and rickettsial infections in Bosnia and Herzegovina, the authors submitted 115 sera of healthy persons to complement-fixation tests with typhus, Q fever, mumps, rickettsialpox, and psittacosis antigens.
  • [MeSH-major] Epidemics. Epidemiologic Studies. Rickettsia Infections / epidemiology. Virus Diseases / epidemiology

  • MedlinePlus Health Information. consumer health - Viral Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hyg (Lond). 1954 Jun;52(2):129-50 [13174794.001]
  • [Cites] Am J Syph Gonorrhea Vener Dis. 1953 May;37(3):237-42 [13040644.001]
  • (PMID = 13383366.001).
  • [ISSN] 0042-9686
  • [Journal-full-title] Bulletin of the World Health Organization
  • [ISO-abbreviation] Bull. World Health Organ.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Not Available
  • [Other-IDs] CLML/ 5731:29901; NLM/ PMC2538166
  • [Keywords] NLM ; RICKETTSIAL DISEASES/epidemiology (major topic) / VIRUS DISEASES/epidemiology (major topic)
  •  go-up   go-down


53. Jerschkewitz D, Horbach I, Gramlich F, Pohle HD, Fehrenbach FJ: [Bacteremia associated with subfebril urinary tract infections (author's transl)]. Immun Infekt; 1979 Dec;7(6):210-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bacteremia associated with subfebril urinary tract infections (author's transl)].
  • Blood samples of 115 patients of both sexes admitted to the hospital with urinary tract infections were examined for bacteremia.
  • Out of 115 patients 12 (10%) had positive blood cultures associated with significant urinary counts (greater than or equal to 10(5) organisms/ml).
  • [MeSH-major] Sepsis / etiology. Urinary Tract Infections / complications
  • [MeSH-minor] Escherichia coli Infections / etiology. Humans

  • MedlinePlus Health Information. consumer health - Sepsis.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 396229.001).
  • [Journal-full-title] Immunität und Infektion
  • [ISO-abbreviation] Immun. Infekt.
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] ENGLAND
  •  go-up   go-down


54. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ; 1993 Oct 16;307(6910):982-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MAIN OUTCOME MEASURES: Symptomatic colds and asthma exacerbations; objective exacerbations of asthma with > or = 50 l/min reduction in mean peak expiratory flow rate when morning and night time readings on days 1-7 after onset of symptoms were compared with rates during an asymptomatic control period; laboratory confirmed respiratory tract infections.
  • 24% of 115 laboratory confirmed non-bacterial infections were associated with reductions in mean peak expiratory flow rate > or = 50 l/min through days 1-7 and 48% had mean decreases > or = 25 l/min.
  • 44% of episodes with mean decreases in flow rate > or = 50 l/min were associated with laboratory confirmed infections.
  • Infections with rhinoviruses, coronaviruses OC43 and 229E, influenza B, respiratory syncytial virus, parainfluenza virus, and chlamydia were all associated with objective evidence of an exacerbation of asthma.
  • CONCLUSIONS: These findings show that asthma symptoms and reductions in peak flow are often associated with colds and respiratory viruses; respiratory virus infections commonly cause or are associated with exacerbations of asthma in adults.
  • [MeSH-major] Asthma / etiology. Respiratory Tract Infections / complications
  • [MeSH-minor] Adult. Base Sequence. Common Cold / microbiology. Common Cold / physiopathology. Female. Humans. Longitudinal Studies. Lung / physiopathology. Male. Middle Aged. Molecular Sequence Data. Peak Expiratory Flow Rate. Recurrence. Respiratory Syncytial Virus Infections / microbiology. Respiratory Syncytial Virus Infections / physiopathology. Respiratory Syncytial Viruses / isolation & purification. Rhinovirus / isolation & purification

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr. 1973 Apr;82(4):578-90 [4349062.001]
  • [Cites] Br Med J. 1972 Aug 5;3(5822):323-7 [4403011.001]
  • [Cites] Ann Intern Med. 1974 Feb;80(2):150-5 [4359738.001]
  • [Cites] Ann Allergy. 1974 Sep;33(3):145-9 [4368435.001]
  • [Cites] J Pediatr. 1974 Oct;85(4):472-7 [4374518.001]
  • [Cites] Am Rev Respir Dis. 1976 Feb;113(2):149-53 [174464.001]
  • [Cites] Am Rev Respir Dis. 1976 Jul;114(1):95-102 [180856.001]
  • [Cites] Ann Intern Med. 1978 Feb;88(2):203-5 [415653.001]
  • [Cites] Am Rev Respir Dis. 1979 Aug;120(2):393-7 [475158.001]
  • [Cites] Arch Dis Child. 1979 Aug;54(8):587-92 [507912.001]
  • [Cites] J Clin Microbiol. 1980 Oct;12(4):493-7 [6252244.001]
  • [Cites] Lancet. 1988 Sep 17;2(8612):679 [2901532.001]
  • [Cites] Thorax. 1988 Sep;43(9):679-83 [3194873.001]
  • [Cites] Epidemiol Infect. 1990 Dec;105(3):609-18 [2249724.001]
  • [Cites] Nucleic Acids Res. 1991 Jul 25;19(14):4008 [1861999.001]
  • [Cites] Thorax. 1991 Oct;46(10):706-11 [1750016.001]
  • [Cites] Lancet. 1992 Feb 8;339(8789):367-8 [1346442.001]
  • [Cites] J Med Virol. 1993 Jun;40(2):96-101 [8395557.001]
  • [Cites] JAMA. 1974 Jan 21;227(3):292-8 [4358170.001]
  • [Cites] Am Rev Respir Dis. 1969 Aug;100(2):141-6 [5805258.001]
  • [Cites] Am J Med. 1972 Jun;52(6):738-46 [5030171.001]
  • [CommentIn] BMJ. 1994 Jan 1;308(6920):57 [8298360.001]
  • (PMID = 8241910.001).
  • [ISSN] 0959-8138
  • [Journal-full-title] BMJ (Clinical research ed.)
  • [ISO-abbreviation] BMJ
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] ENGLAND
  • [Other-IDs] NLM/ PMC1679193
  •  go-up   go-down


55. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR: Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet; 2013 Sep 7;382(9895):877-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study.
  • Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method.
  • During the first 12 months of follow-up, 4·4% (95% CI 3·5-5·6; n=115 incident infections) of men acquired an incident oral HPV infection, 1·7% (1·2-2·5; n=53 incident infections) an oral oncogenic HPV infection, and 0·6% (0·3-1·1; n=18 incident infections) an oral HPV 16 infection.
  • Median duration of infection was 6·9 months (95 % CI 6·2-9·3; n=45 cleared infections) for any HPV, 6·3 months (6·0-9·9; n=18 cleared infections) for oncogenic HPV, and 7·3 months (6·0-not estimable; n=5 cleared infections) for HPV 16.
  • Eight of the 18 incident oral HPV 16 infections persisted for two or more study visits.
  • INTERPRETATION: Newly acquired oral oncogenic HPV infections in healthy men were rare and most were cleared within 1 year.
  • [MeSH-major] Mouth Diseases / epidemiology. Mouth Diseases / virology. Oropharyngeal Neoplasms / epidemiology. Oropharyngeal Neoplasms / virology. Papillomavirus Infections / epidemiology. Papillomavirus Infections / virology

  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 5,000 expert scientists and clinical researchers. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 Elsevier Ltd. All rights reserved.
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2036-43 [18708396.001]
  • [Cites] J Natl Cancer Inst. 2010 Mar 3;102(5):315-24 [20157096.001]
  • [Cites] J Infect Dis. 2009 May 1;199(9):1263-9 [19320589.001]
  • [Cites] Int J Cancer. 2009 Jul 15;125(2):362-6 [19330833.001]
  • [Cites] J Autoimmun. 2010 May;34(3):J258-65 [20042314.001]
  • [Cites] Vaccine. 2010 Apr 26;28(19):3269-72 [20226244.001]
  • [Cites] Sex Transm Dis. 2010 Jun;37(6):386-91 [20081557.001]
  • [Cites] Lancet Oncol. 2010 Aug;11(8):781-9 [20451455.001]
  • [Cites] PLoS One. 2010;5(7):e11918 [20689835.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):172-82 [21148755.001]
  • [Cites] Lancet. 2011 Mar 12;377(9769):932-40 [21367446.001]
  • [Cites] J Infect Dis. 2011 Dec 1;204(11):1711-22 [21964400.001]
  • [Cites] J Clin Oncol. 2011 Nov 10;29(32):4294-301 [21969503.001]
  • [Cites] JAMA. 2012 Feb 15;307(7):693-703 [22282321.001]
  • [Cites] Oral Dis. 2012 Jul;18(5):430-41 [22251072.001]
  • [Cites] Sex Transm Dis. 2012 Jul;39(7):559-66 [22706220.001]
  • [Cites] Sex Transm Dis. 2012 Nov;39(11):860-7 [23064535.001]
  • [Cites] J Natl Cancer Inst. 2013 Feb 6;105(3):175-201 [23297039.001]
  • [Cites] J Clin Microbiol. 2000 Jan;38(1):357-61 [10618116.001]
  • [Cites] Lancet Oncol. 2009 Apr;10(4):321-2 [19350698.001]
  • [Cites] J Virol. 2008 Jun;82(12):6084-5; author reply 6085-6 [18497423.001]
  • [Cites] N Engl J Med. 2001 Apr 12;344(15):1125-31 [11297703.001]
  • [Cites] Am J Epidemiol. 2003 Feb 1;157(3):218-26 [12543621.001]
  • [Cites] J Natl Cancer Inst. 1995 Sep 20;87(18):1365-71 [7658497.001]
  • [Cites] J Clin Microbiol. 1998 Oct;36(10):3020-7 [9738060.001]
  • [Cites] N Engl J Med. 2007 May 10;356(19):1944-56 [17494927.001]
  • [Cites] Lancet. 2007 Sep 8;370(9590):890-907 [17826171.001]
  • [Cites] J Natl Cancer Inst. 2008 Mar 19;100(6):407-20 [18334711.001]
  • [Cites] IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636 [18354839.001]
  • [CommentIn] Lancet. 2013 Sep 7;382(9895):839-41 [23827091.001]
  • [CommentIn] Lancet. 2013 Nov 9;382(9904):1554 [24209828.001]
  • (PMID = 23827089.001).
  • [ISSN] 1474-547X
  • [Journal-full-title] Lancet (London, England)
  • [ISO-abbreviation] Lancet
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA076292; United States / NCI NIH HHS / CA / R01 CA098803; United States / NCI NIH HHS / CA / R01CA098803; United States / NCI NIH HHS / CA / R25 CA147832; United States / NCI NIH HHS / CA / R25T CA147832; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS540562; NLM/ PMC3904652
  •  go-up   go-down


56. Serdar ZA, Eren PA, Canbakan M, Turan K, Tellioglu G, Gülle S, Ozgezer T, Kara M, Berber I, Titiz MI: Dermatologic findings in renal transplant recipients: Possible effects of immunosuppression regimen and p53 mutations. Transplant Proc; 2010 Sep;42(7):2538-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients were categorized into 3 groups according to time since the transplantation procedure.
  • Of 115 lesions, the most commonly observed were verruca vulgaris (n = 34) from viruses, and pityriasis versicolor (n = 21) from superficial fungal infections.
  • [MeSH-minor] Adult. Dermatomycoses / epidemiology. Drug Therapy, Combination. Exons / genetics. Female. Follow-Up Studies. Humans. Male. Middle Aged. Polymorphism, Single-Stranded Conformational. Postoperative Complications / genetics. Precancerous Conditions / genetics. Skin Diseases, Bacterial / epidemiology. Skin Diseases, Viral / epidemiology. Time Factors

  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20832539.001).
  • [ISSN] 1873-2623
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  •  go-up   go-down


57. Marei MA, al-Hamshary AM, Abdalla KF, Abdel-Maaboud AI: A study on secretory IgA in malnourished children with chronic diarrhoea associated with parasitic infections. J Egypt Soc Parasitol; 1998 Dec;28(3):907-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A study on secretory IgA in malnourished children with chronic diarrhoea associated with parasitic infections.
  • In gp I, 75% showed parasitic infections with a significant increase in serum IgA (133.7 +/- 18.9) as compared to gp II (P < 0.001).
  • In gp II, 20% showed parasitic infections with a non significant increase in serum IgA (115.8 +/- 14.2) as compared to gp III.

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9914711.001).
  • [ISSN] 1110-0583
  • [Journal-full-title] Journal of the Egyptian Society of Parasitology
  • [ISO-abbreviation] J Egypt Soc Parasitol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] EGYPT
  • [Chemical-registry-number] 0 / Immunoglobulin A, Secretory
  •  go-up   go-down


58. Rolando N, Gimson A, Philpott-Howard J, Sahathevan M, Casewell M, Fagan E, Westaby D, Williams R: Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol; 1993 Jul;18(3):290-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These infections were significantly more common after emergency sclerotherapy, 40 (34.8%) of 115 sessions, than after elective sclerotherapy, three (3.8%) of 80 sessions (P < or = 0.0001).
  • [MeSH-major] Anti-Bacterial Agents / therapeutic use. Bacterial Infections / etiology. Bacterial Infections / prevention & control. Esophageal Diseases / etiology. Esophageal Diseases / prevention & control. Esophageal and Gastric Varices / therapy. Esophagoscopy / adverse effects. Sclerotherapy / adverse effects
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cilastatin / therapeutic use. Enterobacter cloacae. Enterobacteriaceae Infections / epidemiology. Enterobacteriaceae Infections / etiology. Enterobacteriaceae Infections / prevention & control. Escherichia coli Infections / epidemiology. Escherichia coli Infections / etiology. Escherichia coli Infections / prevention & control. Female. Humans. Imipenem / therapeutic use. Male. Middle Aged. Prospective Studies. Staphylococcal Infections / epidemiology. Staphylococcal Infections / etiology. Staphylococcal Infections / prevention & control. Staphylococcus aureus


59. Chang SJ, Ko YC: Polymerase chain reaction technique for detection of human immunodeficiency virus type I. Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar;7(3):115-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The length of the amplified DNA segment was 115 base pairs (bp) and the appearance of this segment showed positive reaction with the HIV-1 antigen.
  • These six HIV-1 antibody positive cases, including an asymptomatic infant showed a segment size of about 115 bp and were recognized as HIV-1 positive infections, and whereas the HIV-1 antibody negative case did not.
  • [MeSH-major] HIV Infections / diagnosis. HIV-1 / isolation & purification

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1865505.001).
  • [ISSN] 0257-5655
  • [Journal-full-title] Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Gaoxiong Yi Xue Ke Xue Za Zhi
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


60. Zeller V, Lavigne M, Biau D, Leclerc P, Ziza JM, Mamoudy P, Desplaces N: Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections. Joint Bone Spine; 2009 Oct;76(5):491-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections.
  • OBJECTIVE: We compared outcomes of group B streptococcal and other-pathogen prosthetic hip infections.
  • METHODS: One hundred and thirty nine patients, 24 with group B streptococcal and 115 other-pathogen prosthetic hip infections, were included.
  • The primary outcome was the time from surgical treatment to treatment failure, defined as relapse, infection- or treatment-related death.
  • RESULTS: With a median follow-up of 22 months, treatment failed more frequently in patients with group B streptococcal prosthetic hip infections (hazard ratio, 4.88 [95% CI, 1.4-17], P=.012).
  • [MeSH-major] Anti-Bacterial Agents / therapeutic use. Bacterial Infections / epidemiology. Hip Prosthesis / adverse effects. Postoperative Complications / epidemiology. Streptococcal Infections / epidemiology. Streptococcus agalactiae
  • [MeSH-minor] Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Multivariate Analysis. Proportional Hazards Models. Prosthesis Failure. Regression Analysis. Reoperation / statistics & numerical data. Time Factors. Treatment Failure. Treatment Outcome


61. Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroëdan F, Sermet C, Bouvenot G, Eschwège E: Trends in antimicrobial drug use in the community--France, 1981-1992. J Infect Dis; 1998 Feb;177(2):492-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The frequency of respiratory tract infections with a presumed viral etiology that were diagnosed and treated with antibiotics increased by 86% for adults and 115% for children in the 11-year period.
  • The proper use of cephalosporins must be encouraged, and vigilance is required in view of the increased improper use of fluoroquinolones, mainly for respiratory tract infections with a presumed viral etiology.
  • [MeSH-minor] Adult. Anti-Infective Agents / therapeutic use. Cephalosporins / therapeutic use. Child. Data Collection. Fluoroquinolones. France. Humans. Respiratory Tract Infections / drug therapy. Respiratory Tract Infections / virology. Virus Diseases / drug therapy

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9466546.001).
  • [ISSN] 0022-1899
  • [Journal-full-title] The Journal of infectious diseases
  • [ISO-abbreviation] J. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anti-Infective Agents; 0 / Cephalosporins; 0 / Fluoroquinolones
  •  go-up   go-down


62. Khallaf N, el-Ansary S, Hassan M: Acute respiratory infections: sentinel survey in Egypt. World Health Forum; 1996;17(3):297-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute respiratory infections: sentinel survey in Egypt.
  • A survey of 115 health centres in five governorates provided morbidity figures for acute respiratory infections (ARI) from 75,789 records.
  • To obtain accurate data on the incidence and clinical profile of acute respiratory infections (ARI) in Egyptian infants and children aged 4 years and under, 115 randomly selected health centers in five of the country's 26 governorates participated in an ARI Case Registration System.
  • [MeSH-major] Respiratory Tract Infections / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 8756146.001).
  • [ISSN] 0251-2432
  • [Journal-full-title] World health forum
  • [ISO-abbreviation] World Health Forum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] SWITZERLAND
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Other-IDs] PIP/ 115936; POP/ 00256861
  • [Keywords] PIP ; Child (major topic) / Child Health (major topic) / Child Health Services (major topic) / Infant (major topic) / Morbidity (major topic) / Respiratory Infections (major topic) / Signs And Symptoms (major topic) / Surveys (major topic) / Africa / Age Factors / Arab Countries / Delivery Of Health Care / Demographic Factors / Developing Countries / Diseases / Egypt / Health / Health Services / Infections / Maternal-child Health Services / Mediterranean Countries / Northern Africa / Population / Population Characteristics / Primary Health Care / Research Methodology / Sampling Studies / Studies / Youth
  • [General-notes] PIP/ TJ: WORLD HEALTH FORUM.
  •  go-up   go-down


63. Liberatos JD: Schistosoma mansoni: male-biased sex ratios in snails and mice. Exp Parasitol; 1987 Oct;64(2):165-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A significantly higher percentage of male miracidia developed to cercarial production in unimiracidial infections (57 male, 34 female), and a significantly higher percentage of male cercariae developed to adulthood in mice (143 male, 79 female worms resulted from 900 male and 900 female cercariae).
  • No significant differences were found between male and female parasites for longevity of miracidia (both sexes, 10 hr) and cercariae (males 21.3 +/- 5.75 hr, females 25.0 +/- 7.02 hr), prepatent periods in snail hosts (male 34 +/- 2.92 days, females 33 +/- 2.36 days), longevity of snail infections (males 96.6 +/- 25.15 days, females 115.2 +/- 82.43 days), and the numbers of cercariae produced per snail lifetime (males 30,751.44 +/- 18,064.33, females 34,083.00 +/- 33,732.82).
  • [MeSH-minor] Animals. Female. Life Expectancy. Male. Mice / parasitology. Sex Ratio. Snails / parasitology. Time Factors

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3115813.001).
  • [ISSN] 0014-4894
  • [Journal-full-title] Experimental parasitology
  • [ISO-abbreviation] Exp. Parasitol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


64. Barsky AJ, Goodson JD, Lane RS, Cleary PD: The amplification of somatic symptoms. Psychosom Med; 1988 Sep-Oct;50(5):510-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the role of somatosensory amplification, as measured by a self-report questionnaire, in symptomatology, overall discomfort, and disability in 115 patients with upper-respiratory-tract infections who visited an adult medical walk-in clinic.
  • [MeSH-major] Arousal. Respiratory Tract Infections / psychology. Sick Role. Somatoform Disorders / psychology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3186894.001).
  • [ISSN] 0033-3174
  • [Journal-full-title] Psychosomatic medicine
  • [ISO-abbreviation] Psychosom Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


65. Minaei AA, Kowdley KV: ABT-450/ ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus. Expert Opin Pharmacother; 2015 Apr;16(6):929-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: The global prevalence of chronic hepatitis C virus (HCV) is estimated to be 80 - 115 million and currently viremic infections account for 350,000 deaths annually.
  • Additional data is awaited in additional patient populations, and with possible shorter treatment durations.
  • [MeSH-minor] Drug Therapy, Combination. Hepacivirus / drug effects. Hepacivirus / genetics. Humans. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25800085.001).
  • [ISSN] 1744-7666
  • [Journal-full-title] Expert opinion on pharmacotherapy
  • [ISO-abbreviation] Expert Opin Pharmacother
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / ABT-267; 0 / ABT-333; 0 / ABT-450; 0 / Anilides; 0 / Antiviral Agents; 0 / Carbamates; 0 / Macrocyclic Compounds; 0 / Sulfonamides; 56HH86ZVCT / Uracil; O3J8G9O825 / Ritonavir
  • [Keywords] NOTNLM ; ABT-267 (ombitasvir) / ABT-333 (dasabuvir) / ABT-450/r (paritapravir) / hepatitis C virus / ritonavir
  •  go-up   go-down


66. Dubula T, Mody GM: Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol; 2015 Mar;34(3):479-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus.
  • Our aim was to determine reasons for admission, the prevalence and spectrum of infections, and the outcomes in a multiethnic cohort of hospitalized systemic lupus erythematosus (SLE) patients in Durban, South Africa.
  • Active disease and infections accounted for 218 (66.7%) and 115 (35.2%) admissions respectively, with 58 (17.7%) due to both active disease and infection.
  • Overall, 83 patients (49.7%) had 155 infections; pneumonia (36.8%), cutaneous sepsis (18.1%), tuberculosis (13.5%), urinary tract infections (12.9%), and septicemia (7.1%) were the most common.
  • Bacterial infections, including tuberculosis, are common in SLE, and they are a major cause of mortality.

  • Genetic Alliance. consumer health - Lupus.
  • Genetic Alliance. consumer health - Systemic lupus erythematosus.
  • MedlinePlus Health Information. consumer health - Lupus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25535200.001).
  • [ISSN] 1434-9949
  • [Journal-full-title] Clinical rheumatology
  • [ISO-abbreviation] Clin. Rheumatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


67. Kato M, Granich R, Bui DD, Tran HV, Nadol P, Jacka D, Sabin K, Suthar AB, Mesquita F, Lo YR, Williams B: The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr; 2013 Aug 15;63(5):e142-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: From 2011 to 2050, maintaining current interventions will incur an estimated 18,115 new HIV infections and will cost US $22.1 million (reference scenario).
  • Annual HTC and immediate treatment, if offered to all adults, will reduce new HIV infections by 14,513 (80%) and will cost US $76.9 million.
  • Annual HTC and immediate treatment offered only to people who inject drugs will reduce new infections by 13,578 (75%) and will cost only US $23.6 million.
  • Annual HTC and immediate treatment for key populations, combined with scale-up of methadone maintenance therapy and condom use, will reduce new infections by 14,723 (81%) with similar costs (US $22.7 million).
  • [MeSH-major] Anti-Retroviral Agents / therapeutic use. Antiretroviral Therapy, Highly Active / methods. Disease Transmission, Infectious / prevention & control. HIV Infections / epidemiology. HIV Infections / prevention & control


68. Curciarello J, Apraiz M, Chiera A, Castelletto R, Vassia MA, Barbero R, Belloni P, Castelletto E, Jmelnitzky A: [Hepatitis B and C virus in chronic alcoholic patients: prevalence and influence on liver injury]. Acta Gastroenterol Latinoam; 1996;26(4):211-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this prospectively designed study is to analyse the prevalence of HBV and HCV infections in 115 chronic alcohol abusers, their relation to epidemiological variables, and their meaning in pathogenesis and severity of alcoholic liver injury.
  • No differences in histological final diagnosis were found related to HBV and HCV markers reactivity, suggesting no clear influence of viral infections on the severity of liver damage in alcoholics in our series.

  • Genetic Alliance. consumer health - Hepatitis.
  • MedlinePlus Health Information. consumer health - Hepatitis B.
  • MedlinePlus Health Information. consumer health - Hepatitis C.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9335923.001).
  • [ISSN] 0300-9033
  • [Journal-full-title] Acta gastroenterologica Latinoamericana
  • [ISO-abbreviation] Acta Gastroenterol. Latinoam.
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] ARGENTINA
  • [Chemical-registry-number] 0 / Biomarkers
  •  go-up   go-down


69. Chikviladze D, Gachechiladze Kh, Mikeladze M, Metreveli D, Avazashvili D: [Microbiological investigation of diabetic foot infections]. Georgian Med News; 2010 Jun;(183):22-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Microbiological investigation of diabetic foot infections].
  • The aim of the article was to determine the structure of infections agents in diabetic foot infections and their sensibility to antibiotics A total of 295 microbial isolates were obtained from 115 patients with confirmed diabetic foot infection, treated in 2005-2009 years.
  • It is concluded, that success of antimicrobial therapy depends on correct choice of antibiotic, based on in time exposal of etiology of infection, determination of its sensitivity to antimicrobial remedy, considering of its pharmacocinetical features.
  • [MeSH-minor] Aged. Bacterial Infections / complications. Bacterial Infections / drug therapy. Bacterial Infections / microbiology. Follow-Up Studies. Georgia (Republic). Humans. Middle Aged. Prevalence. Pseudomonas aeruginosa / drug effects. Pseudomonas aeruginosa / isolation & purification. Staphylococcus aureus / drug effects. Staphylococcus aureus / isolation & purification

  • MedlinePlus Health Information. consumer health - Antibiotic Resistance.
  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Diabetic Foot.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20622271.001).
  • [ISSN] 1512-0112
  • [Journal-full-title] Georgian medical news
  • [ISO-abbreviation] Georgian Med News
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Georgia (Republic)
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  •  go-up   go-down


70. Paba P, Criscuolo AA, Grazia Giancipoli R, Santi F, Ascone C, Sesti F, Piccione E, Perno CF, Favalli C, Ciotti M: Microbiological Infections in Women With Cervical Cytological Reports of Atypical Squamous Cells of Undetermined Significance. J Low Genit Tract Dis; 2015 Jul;19(3):203-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microbiological Infections in Women With Cervical Cytological Reports of Atypical Squamous Cells of Undetermined Significance.
  • OBJECTIVE: To study the role of cervicovaginal infections in women with cytological reports of atypical squamous cells of undetermined significance (ASC-US).
  • RESULTS: Among the enrolled women, 105 women (47.7%) had ASC-US cytology, whereas 115 women (52.3%) had negative cytology.
  • Microscopy showed infections more frequently in women with ASC-US than in those with negative cytology: 70.5% (74/105) vs 36% (41/115); p < .001.
  • Cocci were present in 73.3% (77/105) of the women with ASC-US and in 43.5% (50/115) of those with negative cytology; p < .001.
  • According to Ison score, 84% (88/105) of ASC-US was grade 0 vs 22% (25/115) of negative cytology, p < .001.
  • A statistically significant correlation between high pH and vaginal infections was found in women aged 20 to 29 (p = .003) and those 50 years or older in both cytological report groups; p < .001.
  • CONCLUSIONS: Cervicovaginal infections are associated with a cytological report of ASC-US.
  • [MeSH-minor] Adolescent. Adult. Aged. Cervix Uteri / microbiology. Female. Humans. Italy / epidemiology. Middle Aged. Papillomaviridae / isolation & purification. Papillomavirus Infections / epidemiology. Vagina / microbiology. Young Adult

  • MedlinePlus Health Information. consumer health - Cervix Disorders.
  • MedlinePlus Health Information. consumer health - Vaginal Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25148228.001).
  • [ISSN] 1526-0976
  • [Journal-full-title] Journal of lower genital tract disease
  • [ISO-abbreviation] J Low Genit Tract Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


71. Schutze GE, Heulitt MJ: Infections during extracorporeal life support. J Pediatr Surg; 1995 Jun;30(6):809-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infections during extracorporeal life support.
  • Little data exist on the type of infections patients acquire during extracorporeal life support.
  • Through a retrospective analysis of 109 patients who underwent 115 episodes of venoarterial extracorporeal life support, it was determined that nosocomial infections developed in 18 patients (16%).
  • Patients with nosocomial infections were supported for longer periods of time (230 versus 140 hours; P < .05) and were more likely to have an open chest (P = .02) than those who did not have infectious complications.
  • Blood-borne infections occurred most often while patients were cannulated for extracorporeal life support, with urinary tract and wound infections more commonly occurring after decannulation.
  • Fungal organisms were isolated in 50% of nosocomial infections.
  • Patients with blood or wound fungal infections had a higher case-fatality rate than those patients with bacterial complications (P = .03).
  • Because it is unlikely that the duration of extracorporeal life support can be shortened significantly, the authors recommend an increased level of awareness of nosocomial infections in patients on prolonged extracorporeal life support.
  • Further research is needed to assess the effects of antifungal prophylaxis or immune modulation to prevent nosocomial infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 7666312.001).
  • [ISSN] 0022-3468
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


72. Pramoolsinsap C, Sirikulchayanonta V, Busakorn W, Poovorawan Y, Hirsch P, Theamboonlers A, Lerdverasirikul P: Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease. Southeast Asian J Trop Med Public Health; 1999 Dec;30(4):741-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Concurrent infections with HGV and/or HCV (HGV/HCV) were investigated in 196 patients with HBV-related chronic liver disease (115 chronic hepatitis, 31 liver cirrhosis, 50 hepatocellular carcinoma), and in 100 HBsAg carriers.

  • Genetic Alliance. consumer health - Hepatitis.
  • Genetic Alliance. consumer health - Liver Disease.
  • MedlinePlus Health Information. consumer health - Hepatitis C.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10928369.001).
  • [ISSN] 0125-1562
  • [Journal-full-title] The Southeast Asian journal of tropical medicine and public health
  • [ISO-abbreviation] Southeast Asian J. Trop. Med. Public Health
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] THAILAND
  • [Chemical-registry-number] 0 / Interferon-alpha
  •  go-up   go-down


73. Domart Y, Trouillet JL, Fagon JY, Chastre J, Brun-Vezinet F, Gibert C: Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest; 1990 Jan;97(1):18-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To determine the incidence and morbidity of infections with CMV associated with mediastinitis after conventional cardiac surgery, 115 consecutive adult patients with mediastinitis were evaluated with viral cultures of blood and urine.
  • [MeSH-major] Cardiac Surgical Procedures. Cytomegalovirus Infections / etiology. Mediastinitis / etiology. Postoperative Complications

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Cytomegalovirus Infections.
  • MedlinePlus Health Information. consumer health - Heart Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Chest. 1990 Jan;97(1):3 [2153066.001]
  • (PMID = 2153065.001).
  • [ISSN] 0012-3692
  • [Journal-full-title] Chest
  • [ISO-abbreviation] Chest
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Antibodies, Viral; 0 / Immunoglobulin G
  •  go-up   go-down


74. Latham RH, Running K, Stamm WE: Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA; 1983 Dec 9;250(22):3063-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urinary tract infections in young adult women caused by Staphylococcus saprophyticus.
  • We evaluated and compared 81 urinary tract infections (UTIs) with Staphylococcus saprophyticus occurring in 72 college women with Escherichia coli UTIs.
  • Staphylococcus saprophyticus infections occurred more frequently during the late summer and early fall.
  • Age, history of previous UTI, signs and symptoms of infection, and findings on urinalysis were similar in patients with S saprophyticus and E coli infections.
  • Nine (41%) of 22 S saprophyticus infections were localized to the upper urinary tract by the antibody-coated bacteria technique compared with 18 (16%) of 115 infections with E coli (P = .01).
  • In vitro susceptibility testing showed almost uniform sensitivity of S saprophyticus to most antimicrobials used to treat UTIs, but recurrent infections occurred in six of the 72 women despite adequate therapy.
  • [MeSH-major] Staphylococcal Infections / etiology. Urinary Tract Infections / etiology

  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 6644988.001).
  • [ISSN] 0098-7484
  • [Journal-full-title] JAMA
  • [ISO-abbreviation] JAMA
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI 18389
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Coagulase
  •  go-up   go-down


75. Gilman RH, Terminel M, Levine MM, Hernandez-Mendosa P, Calderone E, Vasquez V, Martinez E, Snyder MJ, Hornick RB: Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis; 1975 Dec;132(6):630-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Both drug regimens were effective and of comparable value in treatment of chloramphenicol-resistant infections, as measured by duration of fever (124 hr and 115 hr, respectively) and duration of bacteremia (1.0 and 0.4 days, respectively).
  • Trimethoprim-sulfamethoxazole therapy of infections due to chloramphenicol-sensitive S. typhi resulted in more rapid lysis of fever than did amoxicillin therapy.
  • Trimethoprim and sulfamethoxazole were not synergistic in vitro against the chloramphenicol-resistant strain of S. typhi, and the role of sulfamethoxazole in treatment of such infections appears to be minimal.

  • Genetic Alliance. consumer health - Typhoid fever.
  • Hazardous Substances Data Bank. AMOXICILLIN .
  • Hazardous Substances Data Bank. CHLORAMPHENICOL .
  • Hazardous Substances Data Bank. AMPICILLIN .
  • Hazardous Substances Data Bank. SULFAMETHOXAZOLE .
  • Hazardous Substances Data Bank. TRIMETHOPRIM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 127815.001).
  • [ISSN] 0022-1899
  • [Journal-full-title] The Journal of infectious diseases
  • [ISO-abbreviation] J. Infect. Dis.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Drug Combinations; 66974FR9Q1 / Chloramphenicol; 7C782967RD / Ampicillin; 804826J2HU / Amoxicillin; AN164J8Y0X / Trimethoprim; JE42381TNV / Sulfamethoxazole
  •  go-up   go-down


76. Miholic J, Hiertz H, Hudec M, Laczkovics A, Domanig E: Fever, leucocytosis and infection after open heart surgery. A log-linear regression analysis of 115 cases. Thorac Cardiovasc Surg; 1984 Feb;32(1):45-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fever, leucocytosis and infection after open heart surgery. A log-linear regression analysis of 115 cases.
  • Seven out of 115 patients suffered infections during their hospital stay: Bacteremia occurred in 3, pneumonia in 2, and deep sternal wound infection in 2 patients, and a superficial wound infection in one.
  • [MeSH-major] Bacterial Infections / diagnosis. Cardiac Surgical Procedures. Fever / epidemiology. Leukocytosis / epidemiology. Surgical Wound Infection / diagnosis

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Fever.
  • MedlinePlus Health Information. consumer health - Heart Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 6198774.001).
  • [ISSN] 0171-6425
  • [Journal-full-title] The Thoracic and cardiovascular surgeon
  • [ISO-abbreviation] Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] GERMANY, WEST
  •  go-up   go-down


77. Sprunt K, Leidy G, Redman W: Abnormal colonization of neonates in an intensive care unit: means of identifying neonates at risk of infection. Pediatr Res; 1978 Oct;12(10):998-1002
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All infections occurred in the group of infants with abnormal pharyngeal colonization (18 infections in 115 abnormally colonized infants): with a single exception the infecting organism showed the cultural characteristics of the colonizing organism.
  • [MeSH-minor] Anti-Bacterial Agents / therapeutic use. Bacterial Infections / complications. Bacterial Infections / diagnosis. Bacterial Infections / microbiology. Cross Infection / diagnosis. Cross Infection / microbiology. Humans. Hyaline Membrane Disease / complications. Infant, Newborn, Diseases / diagnosis. Infant, Newborn, Diseases / microbiology. Risk. Staphylococcal Infections / microbiology. Staphylococcus aureus / isolation & purification. Streptococcus / isolation & purification

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 724305.001).
  • [ISSN] 0031-3998
  • [Journal-full-title] Pediatric research
  • [ISO-abbreviation] Pediatr. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  •  go-up   go-down


78. Ksssler A, Grünert C, Wood WG: The limitations and usefulness of C-reactive protein and elastase-alpha 1-proteinase inhibitor complexes as analytes in the diagnosis and follow-up of sepsis in newborns and adults. Eur J Clin Chem Clin Biochem; 1994 May;32(5):365-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • C-reactive protein and elastase-alpha 1-proteinase inhibitor complexes were compared in the diagnosis of neonatal sepsis and bacterial infections in adults on the intensive care unit.
  • EDTA-plasma samples (n = 115) from 28 neonates (gestational age 29-42 weeks) within the first 72 hours of life with suspected neonatal sepsis, 2 babies between 14 and 28 days old with B-streptococcus infections and 28 adults on the intensive care unit with positive bacterial cultures were analysed for both analytes.
  • Two adults with long-term infections were followed up over a period of 28 and 65 days respectively.
  • C-reactive protein was undetectable in samples taken at the same time interval after birth from full-terms babies with a gestational age of 41-42 weeks, even in confirmed cases of neonatal sepsis.(ABSTRACT TRUNCATED AT 250 WORDS)
  • [MeSH-major] Bacteremia / diagnosis. C-Reactive Protein / analysis. Leukocyte Elastase. Pancreatic Elastase / analysis. Streptococcal Infections / diagnosis. Streptococcus agalactiae. alpha 1-Antitrypsin / analysis

  • MedlinePlus Health Information. consumer health - Streptococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 8086520.001).
  • [ISSN] 0939-4974
  • [Journal-full-title] European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies
  • [ISO-abbreviation] Eur J Clin Chem Clin Biochem
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] GERMANY
  • [Chemical-registry-number] 0 / alpha 1-Antitrypsin; 0 / alpha 1-antitrypsin-leukocyte elastase complex; 9007-41-4 / C-Reactive Protein; EC 3.4.21.36 / Pancreatic Elastase; EC 3.4.21.37 / Leukocyte Elastase
  •  go-up   go-down


79. Castro M, Crinò A, Papadatou B, Purpura M, Giannotti A, Ferretti F, Colistro F, Mottola L, Digilio MC, Lucidi V, et al: Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21. J Pediatr Gastroenterol Nutr; 1993 Apr;16(3):265-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study we determined IgA antigliadin antibodies (IgA-AGA) in 155 children with DS, and the results were compared with those of the control groups formed by 320 children affected by upper-respiratory tract infections and 115 children with gastrointestinal symptoms but with normal jejunal mucosa.

  • Genetic Alliance. consumer health - Celiac Disease.
  • MedlinePlus Health Information. consumer health - Celiac Disease.
  • MedlinePlus Health Information. consumer health - Down Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 8492253.001).
  • [ISSN] 0277-2116
  • [Journal-full-title] Journal of pediatric gastroenterology and nutrition
  • [ISO-abbreviation] J. Pediatr. Gastroenterol. Nutr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / HLA-DQ Antigens; 0 / HLA-DR Antigens; 0 / anti-IgA; 9007-90-3 / Gliadin
  •  go-up   go-down


80. Gitau RW, Graham SM, Masese LN, Overbaugh J, Chohan V, Peshu N, Richardson BA, Jaoko W, Ndinya-Achola JO, McClelland RS: Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy. AIDS; 2010 Nov 13;24(17):2733-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.
  • OBJECTIVE: To determine the effect of acquisition and treatment of cervical infections on genital HIV-1 shedding in women receiving ART.
  • We compared the prevalence of HIV-1 RNA detection before (baseline) versus during and after treatment of cervical infections.
  • Compared with baseline, detection of HIV-1 RNA was increased when cervical infections were present (adjusted odds ratio 5.7, 95% confidence interval 1.0-30.3, P = 0.04).
  • However, even in the subset of women with cervical HIV-1 RNA levels above the threshold for quantitation, most had low concentrations during cervical infections (median 115, range 100-820 copies per swab).
  • CONCLUSION: Although these data show a statistically significant increase in cervical HIV-1 RNA detection when cervical infections are present, most cervical HIV-1 RNA concentrations were near the threshold for detection, suggesting that infectivity remains low.
  • Antiretroviral therapy appears to limit increases in genital HIV-1 shedding caused by cervical infections.
  • [MeSH-major] Cervix Uteri / virology. HIV Infections / virology. HIV-1 / isolation & purification. Uterine Cervicitis / virology

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • COS Scholar Universe. author profiles.
  • HIV InSite. treatment guidelines - Women and HIV .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Allergy Clin Immunol. 2008 Jul;122(1):22-8 [18602567.001]
  • [Cites] Sex Transm Dis. 2008 Nov;35(11):946-59 [18685546.001]
  • [Cites] AIDS. 2009 Jul 17;23(11):1397-404 [19381076.001]
  • [Cites] AIDS. 2000 Mar 10;14(4):415-21 [10770544.001]
  • [Cites] Sex Transm Dis. 2000 May;27(5):243-8 [10821594.001]
  • [Cites] AIDS. 2001 Jan 5;15(1):105-10 [11192850.001]
  • [Cites] AIDS. 2007 Feb 19;21(4):501-7 [17301569.001]
  • [Cites] Lancet. 1997 Jun 28;349(9069):1868-73 [9217758.001]
  • [Cites] Lancet. 1997 Sep 27;350(9082):922-7 [9314871.001]
  • [Cites] J Infect Dis. 1999 May;179 Suppl 3:S401-4 [10099106.001]
  • [Cites] AIDS. 1999 Feb 4;13(2):155-66 [10202821.001]
  • [Cites] AIDS Res Hum Retroviruses. 2005 Aug;21(8):714-8 [16131311.001]
  • [Cites] J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):38-42 [17106279.001]
  • [Cites] Curr HIV Res. 2003 Jan;1(1):69-86 [15043213.001]
  • (PMID = 20871388.001).
  • [ISSN] 1473-5571
  • [Journal-full-title] AIDS (London, England)
  • [ISO-abbreviation] AIDS
  • [Language] eng
  • [Grant] United States / FIC NIH HHS / TW / 5D43 TW000007; United States / NIAID NIH HHS / AI / AI58698; United States / NIAID NIH HHS / AI / P30 AI027757; United States / NIAID NIH HHS / AI / R01 AI058698; United States / NIAID NIH HHS / AI / R01 AI058698-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA, Viral
  • [Other-IDs] NLM/ NIHMS244138; NLM/ PMC2978313
  •  go-up   go-down


81. Spector M, Mojibian H, Eliseo D, Pollak JS, Reiner E, Arici M, Tal MG: Clinical outcome of the Tal Palindrome chronic hemodialysis catheter: single institution experience. J Vasc Interv Radiol; 2008 Oct;19(10):1434-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Follow-up was available for 115 catheters.
  • Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded.
  • The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well.
  • RESULTS: Patient ranged in age from 35 to 91 years (median, 69 years).
  • The average catheter indwell time was 105 days (range, 1-673 days).
  • Catheter-related infections occurred in 16 of the 115 catheters (13.9%) during the study period and culture-proved bacteremia occurred in four (3.5%).
  • Seven exit site infections were recorded, and 10 catheters (8.7%) developed fibrin sheaths that necessitated catheter exchanges.

  • MedlinePlus Health Information. consumer health - Dialysis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18693044.001).
  • [ISSN] 1535-7732
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Cole CR, Hansen NI, Higgins RD, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Das A, Stoll BJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development’s Neonatal Research Network: Bloodstream infections in very low birth weight infants with intestinal failure. J Pediatr; 2012 Jan;160(1):54-9.e2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bloodstream infections in very low birth weight infants with intestinal failure.
  • OBJECTIVE: To examine pathogens and other characteristics associated with late-onset bloodstream infections (BSIs) in infants with intestinal failure (IF) as a consequence of necrotizing enterocolitis (NEC).
  • Among infants with IF, an increased number of infections was associated with longer hospitalization and duration of PN (median stay: 172 for those with 0 infections, 188 days for those with 1 infection, and 260 days for those with ≥2 infections [P = .06]; median duration of PN: 90, 112, and 115 days, respectively [P = .003]) and decreased achievement of full feeds during hospitalization (87%, 67%, and 50%, respectively; P = .03).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Mosby, Inc. All rights reserved.
  • [Cites] Clin Perinatol. 2010 Mar;37(1):247-72 [20363458.001]
  • [Cites] J Am Diet Assoc. 2010 Mar;110(3):420-6 [20184992.001]
  • [Cites] Infect Control Hosp Epidemiol. 2010 Oct;31(10):1049-56 [20731595.001]
  • [Cites] J Pediatr. 2011 Mar;158(3):390-6 [20961563.001]
  • [Cites] J Pediatr. 2001 Jul;139(1):27-33 [11445790.001]
  • [Cites] Vital Health Stat 11. 2002 May;(246):1-190 [12043359.001]
  • [Cites] Pediatrics. 2002 Aug;110(2 Pt 1):285-91 [12165580.001]
  • [Cites] Semin Perinatol. 2003 Aug;27(4):264-80 [14510317.001]
  • [Cites] J Pediatr Surg. 2004 May;39(5):690-5 [15137001.001]
  • [Cites] Ann Surg. 1978 Jan;187(1):1-7 [413500.001]
  • [Cites] Pediatr Clin North Am. 1985 Oct;32(5):1265-79 [3897990.001]
  • [Cites] JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):453-60 [8748359.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1998 Aug;27(2):131-7 [9702641.001]
  • [Cites] JAMA. 2004 Nov 17;292(19):2357-65 [15547163.001]
  • [Cites] J Pediatr Surg. 2005 May;40(5):755-62 [15937809.001]
  • [Cites] BMC Pediatr. 2005;5:22 [16004613.001]
  • [Cites] Pediatr Res. 2006 Jan;59(1):96-101 [16380405.001]
  • [Cites] Semin Perinatol. 2007 Apr;31(2):104-11 [17462495.001]
  • [Cites] Am J Infect Control. 2008 Jun;36(5):309-32 [18538699.001]
  • [Cites] Pediatrics. 2008 Sep;122(3):e573-82 [18762491.001]
  • [Cites] Am J Clin Nutr. 2008 Dec;88(6):1552-9 [19064515.001]
  • [Cites] Pediatr Infect Dis J. 2009 Dec;28(12):1052-6 [19953725.001]
  • [Cites] Pediatrics. 2010 Feb;125(2):206-13 [20064860.001]
  • [Cites] J Pediatr. 2010 Jun;156(6):941-7, 947.e1 [20171649.001]
  • (PMID = 21840538.001).
  • [ISSN] 1097-6833
  • [Journal-full-title] The Journal of pediatrics
  • [ISO-abbreviation] J. Pediatr.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / U10 HD021364-14; United States / NICHD NIH HHS / HD / U10 HD027851; United States / NICHD NIH HHS / HD / U10 HD027851-11; United States / NICHD NIH HHS / HD / U10 HD027853; United States / NICHD NIH HHS / HD / U10 HD027853-16; United States / NICHD NIH HHS / HD / U10 HD027856; United States / NICHD NIH HHS / HD / U10 HD027904; United States / NICHD NIH HHS / HD / U10 HD027904-09; United States / NCRR NIH HHS / RR / UL1 RR025008; United States / NCRR NIH HHS / RR / UL1 RR025008-01; United States / NCATS NIH HHS / TR / UL1 TR000454
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS309486; NLM/ PMC3419271
  • [Investigator] Jobe AH; Caplan MS; Oh W; Laptook AR; Vohr BR; Stephens BE; Hensman AM; Watson V; Leach TM; Ventura S; Fanaroff AA; Walsh MC; Wilson-Costello D; Newman NS; Siner BS; Schibler K; Donovan EF; Steichen J; Yolton K; Bridges K; Alexander B; Grisby C; Mersmann M; Mincey HL; Shively J; Gratton TL; Goldberg RN; Michael Cotten C; Goldstein R; Auten KJ; Fisher KA; Lohmeyer MB; Stoll BJ; Carlton DP; Adams-Chapman I; Hale EC; Higgins RD; Wright LL; McClure EM; Stephanie WA; Poindexter BB; Lemons JA; Dusick AM; Herron DE; Miller LC; Das A; Kenneth Poole W; O'Donnell Auman J; Cunningham M; Hastings BK; McClure EM; Petrie Huitema CM; Pickett JW; Schaefer SE; Zaterka Baxter KM; Van Meurs KP; Stevenson DK; Hintz SR; Bethany Ball M; Fleisher BE; De-Battista AM; Baran JM; Bond LE; Bentley B; Brudos GK; Pyle RP; St John NH; Carlo WA; Ambalavanan N; Dimmitt R; Peralta-Carcelen M; Collins MV; Cosby SS; Phillips V; Finer NN; Kaegi D; Rasmussen MR; Vaucher YE; Wozniak PR; Arnell K; Demetrio C; Fuller MG; Henderson C; Rich W; Bauer CR; Duara S; Everett-Thomas R; Hamlin-Smith K; Hiriart-Fajardo S; Frade Eguaras SM; Gideon YC; Mathews EO; Diaz AN; Garcia A; Phelps DL; Myers G; Reubens LJ; Burnell E; Jensen R; Hust D; Rowan M; Yost K; Lauren Zwetsch P; Merzbach J; Kushner E; Sanchez PJ; Laptook AR; Rosenfeld CR; Salhab WA; Sue Broyles R; Heyne RJ; Hensley G; Hickman JF; Madison S; Miller NA; Morgan JS; Guzman A; Heyne E; Madden LA; Adams S; Dooley C; Boatman C; Tyson JE; Kennedy KA; Bradt PJ; Evans P; Major-Kincade T; Morris BH; Whitely LL; Alaniz NI; Akpa EG; Cedillo M; Cluff PA; Dieterich S; Franco CI; Green C; Lis AE; McDavid GE; Reddoch S; Simmons MC; Pierce Tate PL; Wright SL; O'Shea T; Dillard RG; Washburn LK; Goldstein CD; Jackson BG; Peters NJ; Peterson C; Waldrep EL; Whalen Morris M; Hounshell GW; Shankaran S; Johnson YR; Pappas A; Bara R; Muran G; Kennedy D; Goldston LA; Ehrenkranz RA; Gettner P; Konstantino M; Poulsen J; Romano E; Taft J; Williams J
  •  go-up   go-down


83. Nitsch-Osuch A, Kuchar E, Kosmala A, Zycinska K, Wardyn K: Nosocomial rotovirus gastroenetrocolitis in children hospitalized primarily due to respiratory infections. Adv Exp Med Biol; 2013;755:267-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nosocomial rotovirus gastroenetrocolitis in children hospitalized primarily due to respiratory infections.
  • The aim of our study was to analyze the epidemiology of NRVG in a pediatric hospital in Warsaw, Poland, where the majority of children was admitted due to respiratory tract infections.
  • Primary causes of hospitalization of the children with nosocomial rotavirus gastroenterocolitis were respiratory tract infections (including pneumonia, bronchitis, and otitis media) present in 287 cases (61.2%).
  • The nosocomial rotavirus infection was mostly diagnosed among patients aged 6 months - 2 years (201 cases, 42.8%), less common were infections among infants younger than 6 months (133 cases, 28.3%) and children aged 2-6 (115 cases, 24.5%).
  • In conclusion, rotavirus gastroenteritis is the most important nosocomial infection in children hospitalized due to respiratory tract infections and can prolong their hospital stay.
  • [MeSH-major] Cross Infection / epidemiology. Gastroenteritis / epidemiology. Respiratory Tract Infections / complications. Rotavirus Infections / epidemiology

  • MedlinePlus Health Information. consumer health - Gastroenteritis.
  • MedlinePlus Health Information. consumer health - Rotavirus Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22826076.001).
  • [ISSN] 0065-2598
  • [Journal-full-title] Advances in experimental medicine and biology
  • [ISO-abbreviation] Adv. Exp. Med. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Falkensammer B, Walder G, Busch D, Giessauf A, Dierich M, Würzner R: Epidemiology of rubella infections in Austria: important lessons to be learned. Eur J Clin Microbiol Infect Dis; 2004 Jun;23(6):502-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of rubella infections in Austria: important lessons to be learned.
  • In order to ascertain the epidemiology of rubella infections in Austria, a seroepidemiological study was performed.
  • Data collected from 115 cases diagnosed at the Institute of Hygiene and Social Medicine of the University of Innsbruck during 2001 were evaluated.
  • (ii) only a few patients complained of fever, while symptoms such as rash and lymphadenopathy, which are also associated with several other viral infections, including HIV, were found frequently; and (iii) the 115 rubella cases detected in the 1-year study period represented an incidence of >13 per 100,000 population.

  • Genetic Alliance. consumer health - Rubella.
  • MedlinePlus Health Information. consumer health - Rubella.
  • HIV InSite. treatment guidelines - HIV InSite .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15148653.001).
  • [ISSN] 0934-9723
  • [Journal-full-title] European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
  • [ISO-abbreviation] Eur. J. Clin. Microbiol. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Rubella Vaccine
  •  go-up   go-down


85. Hussey G, Kibel M, Dempster W: The serodiagnosis of tuberculosis in children: an evaluation of an ELISA test using IgG antibodies to M. tuberculosis, strain H37 RV. Ann Trop Paediatr; 1991;11(2):113-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mean (SD) optical density value in these patients was 0.115 (0.122) compared with 0.022 (0.017) in the control group of patients who had non-tuberculous acute respiratory tract infections.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 1715140.001).
  • [ISSN] 0272-4936
  • [Journal-full-title] Annals of tropical paediatrics
  • [ISO-abbreviation] Ann Trop Paediatr
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Immunoglobulin G
  •  go-up   go-down


86. Witt MD, Seaberg EC, Darilay A, Young S, Badri S, Rinaldo CR, Jacobson LP, Detels R, Thio CL: Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis; 2013 Jul;57(1):77-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: During 55 343 person-years (PYs) of follow-up, there were 115 incident HCV infections (incidence rate, 2.08/1000 PYs) scattered throughout the study period.
  • In a multivariable analysis with time-varying covariates, older age (incidence rate ratio [IRR], 1.40/10 years, P < .001), enrollment in the later (2001-2003) recruitment period (IRR, 3.80, P = .001), HIV infection (IRR, 5.98, P < .001), drinking >13 alcoholic drinks per week (IRR, 1.68, P < .001), hepatitis B surface antigen positivity (IRR, 1.68, P < .001), syphilis (IRR, 2.95, P < .001), and unprotected receptive anal intercourse with >1 male partner (IRR, 3.37, P < .001) were independently associated with incident HCV.

  • Genetic Alliance. consumer health - Hepatitis.
  • MedlinePlus Health Information. consumer health - Hepatitis C.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS. 2011 May 15;25(8):1083-91 [21537114.001]
  • [Cites] Am J Trop Med Hyg. 2005 Jul;73(1):44-9 [16014830.001]
  • [Cites] Public Health. 2012 Mar;126(3):196-8 [22206985.001]
  • [Cites] Clin Infect Dis. 2012 Nov 15;55(10):1408-16 [22893583.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2011 Jul 22;60(28):945-50 [21775948.001]
  • [Cites] Clin Infect Dis. 2005 Aug 1;41(3):395-402 [16007539.001]
  • [Cites] Am J Epidemiol. 1987 Aug;126(2):310-8 [3300281.001]
  • [Cites] Sex Transm Infect. 2006 Aug;82(4):298-300 [16877578.001]
  • [Cites] AIDS. 2007 May 11;21(8):983-91 [17457092.001]
  • [Cites] J Infect Dis. 2007 Jul 15;196(2):230-8 [17570110.001]
  • [Cites] AIDS. 2007 Oct 1;21(15):2112-3 [17885306.001]
  • [Cites] Sex Transm Infect. 2008 Apr;84(2):111-5 [17932125.001]
  • [Cites] J Infect Dis. 2008 Apr 15;197(8):1213-4, author reply 1214-5 [18462168.001]
  • [Cites] AIDS. 2009 Jul 31;23(12):F1-7 [19542864.001]
  • [Cites] AIDS Patient Care STDS. 2009 Nov;23(11):915-23 [19877800.001]
  • [Cites] Sex Transm Infect. 2010 Feb;86(1):25-8 [19841001.001]
  • [Cites] Sex Transm Dis. 2011 Mar;38(3):219-20 [20938373.001]
  • [Cites] PLoS One. 2011;6(3):e17781 [21408083.001]
  • [Cites] Hepatology. 2002 Sep;36(3):737-42 [12198668.001]
  • [Cites] Am J Epidemiol. 1987 Oct;126(4):568-77 [3651095.001]
  • [Cites] Hepatology. 1997 Sep;26(3 Suppl 1):66S-70S [9305667.001]
  • [Cites] J Clin Microbiol. 1997 Dec;35(12):3274-7 [9399533.001]
  • [CommentIn] Clin Infect Dis. 2014 Jan;58(1):137 [24046308.001]
  • [CommentIn] Clin Infect Dis. 2014 Jan;58(1):136 [24046306.001]
  • (PMID = 23532480.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI-35041; United States / NIMH NIH HHS / MH / P30 MH058107; United States / NCATS NIH HHS / TR / UL1 TR000124; United States / NCRR NIH HHS / RR / UL1-RR025005; United States / NIAID NIH HHS / AI / UO1-AI-35039; United States / NIAID NIH HHS / AI / UO1-AI-35040; United States / NIAID NIH HHS / AI / UO1-AI-35042; United States / NIAID NIH HHS / AI / UO1-AI-35043
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3669529
  • [Keywords] NOTNLM ; MSM / incident HCV / sexual transmission
  •  go-up   go-down


87. Yusof R, Lau YL, Mahmud R, Fong MY, Jelip J, Ngian HU, Mustakim S, Hussin HM, Marzuki N, Mohd Ali M: High proportion of knowlesi malaria in recent malaria cases in Malaysia. Malar J; 2014;13:168
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twelve mixed infections were detected, including P. knowlesi/P. vivax (n = 10), P. knowlesi/P. falciparum (n = 1), and P. falciparum/P. vivax (n = 1).
  • Notably, P. knowlesi (Included mixed infections involving P. knowlesi (P. knowlesi/P. vivax and P. knowlesi /P. falciparum)) showed the highest proportion in Sabah (84/115 cases, prevalence of 73.0%), Sarawak (83/120, 69.2%), Kelantan (42/56, 75.0%), Pahang (24/25, 96.0%), Johor (7/9, 77.8%), and Terengganu (4/5, 80.0%,).

  • Genetic Alliance. consumer health - Malaria.
  • MedlinePlus Health Information. consumer health - Malaria.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Trop Med Hyg. 1968 May;17(3):355-8 [4385130.001]
  • [Cites] Malar J. 2004 Mar 31;3:8 [15056392.001]
  • [Cites] J Clin Lab Anal. 1995;9(6):387-91 [8587007.001]
  • [Cites] Int J Parasitol. 1997 Oct;27(10):1135-45 [9394184.001]
  • [Cites] Am J Trop Med Hyg. 1999 Apr;60(4):687-92 [10348249.001]
  • [Cites] J Trop Med Hyg. 1963 Jun;66:156-8 [13960457.001]
  • [Cites] Emerg Infect Dis. 2004 Dec;10(12):2211-3 [15663864.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1087-8 [16725166.001]
  • [Cites] Clin Infect Dis. 2008 Jan 15;46(2):165-71 [18171245.001]
  • [Cites] Clin Infect Dis. 2008 Jan 15;46(2):172-3 [18171246.001]
  • [Cites] Mol Phylogenet Evol. 2008 Apr;47(1):45-53 [18334303.001]
  • [Cites] Emerg Infect Dis. 2008 May;14(5):811-3 [18439369.001]
  • [Cites] Emerg Infect Dis. 2008 May;14(5):814-6 [18439370.001]
  • [Cites] Int J Parasitol. 2009 Aug;39(10):1125-8 [19358848.001]
  • [Cites] Malar J. 2009;8:249 [19878553.001]
  • [Cites] J Clin Microbiol. 2009 Dec;47(12):4173-5 [19812279.001]
  • [Cites] Emerg Infect Dis. 2010 Jun;16(6):1033-4 [20507769.001]
  • [Cites] Trop Biomed. 2010 Apr;27(1):1-12 [20562807.001]
  • [Cites] Emerg Infect Dis. 2010 Sep;16(9):1476-8 [20735938.001]
  • [Cites] Malar J. 2010;9:370 [21176207.001]
  • [Cites] Malar J. 2012;11:213 [22727041.001]
  • [Cites] Malar J. 2012;11:401 [23216947.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(1):e2026 [23359830.001]
  • [Cites] Infect Genet Evol. 2013 Aug;18:213-9 [23727342.001]
  • [Cites] Malar J. 2013;12:264 [23902626.001]
  • [Cites] J Clin Microbiol. 2004 Jan;42(1):16-20 [14715726.001]
  • [Cites] Lancet. 2004 Mar 27;363(9414):1017-24 [15051281.001]
  • [Cites] Mol Biochem Parasitol. 1993 Oct;61(2):315-20 [8264734.001]
  • (PMID = 24886266.001).
  • [ISSN] 1475-2875
  • [Journal-full-title] Malaria journal
  • [ISO-abbreviation] Malar. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 18S
  • [Other-IDs] NLM/ PMC4016780
  •  go-up   go-down


88. Marco H, Smith RM, Jones RB, Guerry MJ, Catapano F, Burns S, Chaudhry AN, Smith KG, Jayne DR: The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord; 2014;15:178
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Median rituximab dose was 6 g (1-20.2) and total follow-up was 8012 patient-months.
  • 45/115 (39%) with IgG ≥ 6 g/L versus 26/62 (42%) with IgG <6 g/L experienced severe infections (p=0.750).
  • Severe infections were common but were not associated with immunoglobulin levels.

  • MedlinePlus Health Information. consumer health - Autoimmune Diseases.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Rheum. 2012 Apr;64(4):1215-26 [22231479.001]
  • [Cites] PLoS One. 2012;7(5):e37626 [22629432.001]
  • [Cites] Arthritis Rheum. 2012 Nov;64(11):3760-9 [22729997.001]
  • [Cites] Arthritis Rheum. 2012 Nov;64(11):3770-8 [22730028.001]
  • [Cites] J Clin Immunol. 2013 Feb;33(2):388-96 [23064976.001]
  • [Cites] Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):106-11 [23276889.001]
  • [Cites] Ann Rheum Dis. 2013 Sep 1;72(9):1496-502 [23136242.001]
  • [Cites] Ann Rheum Dis. 2012 Mar;71(3):327-33 [22021864.001]
  • [Cites] Clin Nephrol. 2001 Jan;55(1):31-8 [11200865.001]
  • [Cites] Blood. 2004 Mar 1;103(5):1971-2 [14976066.001]
  • [Cites] N Engl J Med. 2004 Jun 17;350(25):2572-81 [15201414.001]
  • [Cites] J Clin Oncol. 1998 Aug;16(8):2825-33 [9704735.001]
  • [Cites] Bone Marrow Transplant. 2005 Jan;35(2):207-8 [15531902.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Jan 15;173(2):180-7 [16224107.001]
  • [Cites] Arthritis Rheum. 2006 May;54(5):1390-400 [16649186.001]
  • [Cites] Eur J Haematol. 2006 Sep;77(3):226-32 [16923109.001]
  • [Cites] Arthritis Rheum. 2006 Sep;54(9):2970-82 [16947528.001]
  • [Cites] Arthritis Rheum. 2006 Sep;54(9):2793-806 [16947627.001]
  • [Cites] Blood. 2006 Nov 15;108(10):3295-301 [16873669.001]
  • [Cites] Arthritis Rheum. 2007 Dec;56(12):3896-908 [18050221.001]
  • [Cites] Ann Rheum Dis. 2008 Sep;67(9):1322-7 [18055469.001]
  • [Cites] Bone Marrow Transplant. 2009 May;43(9):701-8 [19029963.001]
  • [Cites] Ann Rheum Dis. 2009 Jul;68(7):1125-30 [18713783.001]
  • [Cites] Arthritis Rheum. 2009 Jul;60(7):2156-68 [19565480.001]
  • [Cites] Semin Arthritis Rheum. 2009 Aug;39(1):18-29 [18620738.001]
  • [Cites] Clin Otolaryngol. 2009 Aug;34(4):328-35 [19673980.001]
  • [Cites] Arthritis Rheum. 2010 Jan;62(1):222-33 [20039413.001]
  • [Cites] J Rheumatol. 2010 Mar;37(3):558-67 [20110520.001]
  • [Cites] Int J Hematol. 2010 Apr;91(3):501-8 [20217285.001]
  • [Cites] N Engl J Med. 2010 Jul 15;363(3):211-20 [20647198.001]
  • [Cites] N Engl J Med. 2010 Jul 15;363(3):221-32 [20647199.001]
  • [Cites] Arthritis Rheum. 2010 Aug;62(8):2458-66 [20506527.001]
  • [Cites] Nat Rev Rheumatol. 2010 Sep;6(9):547-52 [20647994.001]
  • [Cites] Arthritis Rheum. 2010 Sep;62(9):2625-32 [20506353.001]
  • [Cites] Nephrol Dial Transplant. 2010 Nov;25(11):3586-92 [20466686.001]
  • [Cites] Clin Rheumatol. 2011 Sep;30(9):1241-5 [21523362.001]
  • [Cites] J Rheumatol. 2012 Jan;39(1):125-30 [22089465.001]
  • [Cites] Rheumatology (Oxford). 2012 Apr;51(4):634-43 [21613248.001]
  • (PMID = 24884562.001).
  • [ISSN] 1471-2474
  • [Journal-full-title] BMC musculoskeletal disorders
  • [ISO-abbreviation] BMC Musculoskelet Disord
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / / 100140
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Immunoglobulins; 0 / Immunologic Factors; 4F4X42SYQ6 / Rituximab
  • [Other-IDs] NLM/ PMC4038057
  •  go-up   go-down


89. Hoffman KW, Sachs D, Bardina SV, Michlmayr D, Rodriguez CA, Sum J, Foster GA, Krysztof D, Stramer SL, Lim JK: Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection. J Infect Dis; 2016 Aug 15;214(4):634-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: To better understand the interindividual variability associated with the majority of WNV infections, we evaluated the association of cytokine/chemokine production and outcome of infection among 115 WNV-positive US blood donors identified in 2008-2011.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
  • (PMID = 27142077.001).
  • [ISSN] 1537-6613
  • [Journal-full-title] The Journal of infectious diseases
  • [ISO-abbreviation] J. Infect. Dis.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI108715
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC4957436 [Available on 08/15/17]
  • [Keywords] NOTNLM ; blood bank / blood donations / clinical outcome / early symptomatology / susceptibility
  •  go-up   go-down


90. Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. J Med Assoc Thai; 2004 Nov;87(11):1349-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was no difference between the prevalence of these infections in Bangkok and provincial areas (p = 0.115).
  • [MeSH-major] HIV Infections / complications. HIV Infections / epidemiology. Hepatitis B / complications. Hepatitis B / epidemiology. Hepatitis C / complications. Hepatitis C / epidemiology


91. Levecke B, Buttle DJ, Behnke JM, Duce IR, Vercruysse J: Cysteine proteinases from papaya (Carica papaya) in the treatment of experimental Trichuris suis infection in pigs: two randomized controlled trials. Parasit Vectors; 2014;7:255
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We therefore conducted two randomized controlled trials in pigs to assess the efficacy of papaya CPs against experimental infections with T. suis.
  • METHODS: First, we assessed efficacy by means of egg (ERR) and adult worm reduction rate (WRR) of a single-oral dose of 450 μmol active CPs (CP450) against low (inoculum of 300 eggs) and high (inoculum of 3,000 eggs) intensity T. suis infections and compared the efficacy with those obtained after a single-oral dose of 400 mg albendazole (ALB).
  • In the second trial, we determined and compared the efficacy of a series of CP doses (45 [CP45], 115 [CP115], 225 [CP225], and 450 [CP450] μmol) against high intensity infections.
  • When the efficacy was assessed by ERR, a significant difference was only observed for high intensity infections, CP450 being more efficacious than ALB (98.9% vs. 59.0%).
  • CONCLUSIONS: A single dose of 450 μmol CPs provided greater efficacy against T. suis infections in pigs than a single-oral dose of 400 mg ALB.

  • Hazardous Substances Data Bank. ALBENDAZOLE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Negl Trop Dis. 2011;5(3):e948 [21468309.001]
  • [Cites] Parasit Vectors. 2011;4:36 [21406090.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Jun;5(6):e1138 [21695247.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2011 Oct;105(10):586-90 [21885077.001]
  • [Cites] PLoS One. 2011;6(9):e25003 [21980373.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Dec;5(12):e1457 [22216366.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2012 Feb;106(2):128-30 [22189084.001]
  • [Cites] PLoS Negl Trop Dis. 2012 Jan;6(1):e1417 [22235353.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(6):e1685 [22679525.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(3):e2119 [23556013.001]
  • [Cites] Pathog Glob Health. 2013 Jun;107(4):207-9 [23816513.001]
  • [Cites] J Trop Pediatr (Lond). 1955 Dec;1(3):174-87 [24543887.001]
  • [Cites] Vet Parasitol. 2014 Mar 17;201(1-2):48-58 [24462509.001]
  • [Cites] J Helminthol. 2015 Mar;89(2):165-74 [24176056.001]
  • [Cites] Parasitol Today. 2000 Feb;16(2):71-4 [10652492.001]
  • [Cites] Clin Microbiol Rev. 2000 Apr;13(2):207-22 [10755998.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):685-90 [12625151.001]
  • [Cites] Bull World Health Organ. 2003;81(1):35-42 [12640474.001]
  • [Cites] Acta Trop. 2003 May;86(2-3):141-59 [12745134.001]
  • [Cites] Bull World Health Organ. 2003;81(5):343-52 [12856052.001]
  • [Cites] Plant J. 2004 Feb;37(3):370-8 [14731257.001]
  • [Cites] Biochim Biophys Acta. 1985 Apr 5;828(2):196-204 [3919769.001]
  • [Cites] Biol Chem Hoppe Seyler. 1990 Nov;371(11):1083-8 [2085414.001]
  • [Cites] J Ethnopharmacol. 1995 Nov 3;48(3):161-4 [8719976.001]
  • [Cites] Arch Dis Child. 1953 Aug;28(140):329-31 [13081173.001]
  • [Cites] Parasitology. 2006 May;132(Pt 5):681-9 [16448585.001]
  • [Cites] Parasitology. 2007 Jan;134(Pt 1):103-12 [17032468.001]
  • [Cites] Parasitology. 2007 Sep;134(Pt 10):1409-19 [17475089.001]
  • [Cites] Parasitology. 2007 Nov;134(Pt 12):1831-8 [17640402.001]
  • [Cites] JAMA. 2008 Apr 23;299(16):1937-48 [18430913.001]
  • [Cites] PLoS Negl Trop Dis. 2008;2(10):e322 [18923706.001]
  • [Cites] Clin Infect Dis. 2010 Dec 15;51(12):1420-8 [21062129.001]
  • [Cites] Am J Trop Med Hyg. 2011 May;84(5):792-800 [21540391.001]
  • (PMID = 24886388.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anthelmintics; 0 / Plant Proteins; EC 3.4.- / Cysteine Proteases; F4216019LN / Albendazole
  • [Other-IDs] NLM/ PMC4049439
  •  go-up   go-down


92. Hayashi I, Inoue M, Hashimoto H: Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drugs Exp Clin Res; 1994;20(6):225-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
  • A clinical investigation of methicillin-resistant Staphylococcus aureus (MRSA) infections to study the efficacy of arbekacin (ABK) was carried out by the MRSA Forum composed of 18 groups from 115 institutions in Japan.
  • Most of them (94.6%/96.4%) had primary disease and suffered from pneumonia (38/175), sepsis (6/35) and other infections (30/64).
  • Pure infection by MRSA was noted in 41/159 and polymicrobial infection with MRSA in 33/115.
  • [MeSH-major] Aminoglycosides. Anti-Bacterial Agents. Dibekacin / analogs & derivatives. Methicillin Resistance. Staphylococcal Infections / drug therapy

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 7758394.001).
  • [ISSN] 0378-6501
  • [Journal-full-title] Drugs under experimental and clinical research
  • [ISO-abbreviation] Drugs Exp Clin Res
  • [Language] eng
  • [Publication-type] Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study
  • [Publication-country] SWITZERLAND
  • [Chemical-registry-number] 0 / Aminoglycosides; 0 / Anti-Bacterial Agents; 45ZFO9E525 / Dibekacin; G7V6SLI20L / habekacin
  •  go-up   go-down


93. Michelow P, Dezube BJ, Pantanowitz L: Fine needle aspiration of salivary gland masses in HIV-infected patients. Diagn Cytopathol; 2012 Aug;40(8):684-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most diagnoses were benign and comprised 168 (33.9%) reactive lymphadenopathy, 115 (23.2%) benign lymphoepithelial cysts, 62 (12.5%) mycobacterial infections, and 52 (10.5%) abscesses, of which 10 had associated mycobacterial infections.
  • [MeSH-major] HIV Infections / complications. HIV Infections / pathology. Salivary Gland Neoplasms / complications. Salivary Gland Neoplasms / pathology. Salivary Glands / pathology

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Wiley Periodicals, Inc.
  • (PMID = 22807383.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


94. Gaviria M, Rivera V, Muñoz-Cadavid C, Cano LE, Naranjo TW: Validation and clinical application of a nested PCR for paracoccidioidomycosis diagnosis in clinical samples from Colombian patients. Braz J Infect Dis; 2015 Jul-Aug;19(4):376-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, we have validated and evaluated a nested PCR assay targeting the gene encoding the Paracoccidioides gp43 membrane protein in 191 clinical samples: 115 samples from patients with proven infections other than paracoccidioidomycosis, 51 samples as negative controls, and 25 samples from patients diagnosed with paracoccidioidomycosis.

  • Genetic Alliance. consumer health - Paracoccidioidomycosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2015 Elsevier Editora Ltda. All rights reserved.
  • (PMID = 26100437.001).
  • [ISSN] 1678-4391
  • [Journal-full-title] The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
  • [ISO-abbreviation] Braz J Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / DNA, Fungal; 0 / Fungal Proteins
  • [Keywords] NOTNLM ; Molecular diagnosis / Nested PCR / Paracoccidioides brasiliensis / Paracoccidioidomycosis
  •  go-up   go-down


95. Näher H, Hofmann H, Petzoldt D: [Detection of Chlamydia trachomatis antigen with an enzyme immunoassay]. Hautarzt; 1986 Jan;37(1):37-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Urogenital C. trachomatis infections were diagnosed with the cell culture in 14 of 122 male STD patients (12%), in 12 of 79 female STD patients (15%), in 23 of 89 prostitutes (26%), and in 3 of 115 asymptomatic males (3%).
  • Because it can be performed rapidly and simply and reaches detection rates approaching those of the cell culture method, the enzyme immunoassay is an improvement in the diagnosis of C. trachomatis infections.
  • [MeSH-major] Antigens, Bacterial / analysis. Chlamydia Infections / immunology. Chlamydia trachomatis / immunology. Immunoenzyme Techniques. Urethritis / immunology. Uterine Cervicitis / immunology

  • Genetic Alliance. consumer health - Chlamydia.
  • MedlinePlus Health Information. consumer health - Chlamydia Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3512482.001).
  • [ISSN] 0017-8470
  • [Journal-full-title] Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
  • [ISO-abbreviation] Hautarzt
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] GERMANY, WEST
  • [Chemical-registry-number] 0 / Antigens, Bacterial
  •  go-up   go-down


96. Choubisa SL, Jaroli VJ, Choubisa P, Mogra N: Intestinal parasitic infection in Bhil tribe of Rajasthan, India. J Parasit Dis; 2012 Oct;36(2):143-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A total of 224 Bhil tribal individuals (115 males and 109 females) of different age groups inhabiting tribal rural areas of Udaipur district of Rajasthan, India were investigated for the prevalence of intestinal parasitic (protozoan and helminths) infections.
  • Out of 116 infected tribal subjects, 53 (23.66 %), 33 (14.73 %) and 30 (13.39 %) were infected with protozoan, helminths and mixed (protozoan + helminths) parasitic infections, respectively.
  • Maximum number of parasitic infections occurred in the age group of 6-10 years (69.23 %) in both sexes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24082517.001).
  • [ISSN] 0971-7196
  • [Journal-full-title] Journal of parasitic diseases : official organ of the Indian Society for Parasitology
  • [ISO-abbreviation] J Parasit Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3427671
  • [Keywords] NOTNLM ; Bhil tribe / Helminths / India / Intestinal parasites / Prevalence / Protozoan / Rajasthan
  •  go-up   go-down


97. Kruatrachue M, Na-Nakorn S: A marked reduction in the incidence of cold haemagglutinin in Plasmodium falciparum malaria. Ann Trop Med Parasitol; 1976 Dec;70(4):375-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A survey of cold haemagglutinin using the normal and tyrpsinized group O red blood cells was performed in 101 normal individuals, 139 individuals with Plasmodium falciparum malaria, 115 individuals with various infections other than malaria and 46 cases of auto-immune haemolytic anaemia.
  • Although this was also found in other infections, the proposed mechanism seems to be different.

  • Genetic Alliance. consumer health - Malaria.
  • MedlinePlus Health Information. consumer health - Malaria.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 793545.001).
  • [ISSN] 0003-4983
  • [Journal-full-title] Annals of tropical medicine and parasitology
  • [ISO-abbreviation] Ann Trop Med Parasitol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 0 / Agglutinins; 0 / Hemagglutinins
  •  go-up   go-down


98. Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Alizadeh H, Gharagozlou M, Kalantari N, Sajedi V, Shafiei A, Parvaneh N, Mohammadpour M, Karimi N, Sadaghiani MS, Rezaei N: Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology; 2010 Feb;15(2):289-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Early diagnosis and appropriate treatment reduces the incidence of pulmonary infections in both groups of patients.
  • METHODS: Pulmonary complications were evaluated in 115 patients (76 with CVID and 39 with XLA) by reviewing hospital records of chest infections, pulmonary function tests and high-resolution CT scans.
  • RESULTS: Thirty-two patients with XLA (82%) presented with 59 episodes of pneumonia before diagnosis, whereas 15 patients (38.4%) experienced pneumonia after immunoglobulin replacement therapy (1.67 vs 0.45 episodes per patient per year).
  • Among the CVID patients, 196 episodes of pneumonia were documented in 59 patients (77.6%) before diagnosis, while 36 patients (47.3%) experienced pneumonia after therapy (1.11 vs 0.58 episodes of pneumonia per patient per year).
  • Early diagnosis of patients with primary antibody deficiencies and adequate i.v. immunoglobulin replacement therapy substantially reduces the number of pulmonary infections.

  • Genetic Alliance. consumer health - Common Variable Immunodeficiency.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20051045.001).
  • [ISSN] 1440-1843
  • [Journal-full-title] Respirology (Carlton, Vic.)
  • [ISO-abbreviation] Respirology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


99. File TM Jr, Wilcox MH, Stein GE: Summary of ceftaroline fosamil clinical trial studies and clinical safety. Clin Infect Dis; 2012 Sep;55 Suppl 3:S173-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In October 2010, the new cephalosporin, ceftaroline fosamil, was approved by the US Food and Drug Administration for therapy of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSIs).
  • For both indications, therapy with ceftaroline fosamil was observed to be noninferior to the comparator agents (ceftriaxone for CABP and vancomycin plus aztreonam for ABSSSIs) at both a standard test of cure assessment time (8-15 days after discontinuation of study drug) and an early assessment time point (day 3 or 4 of study).
  • Notably, the clinical cure rates in ME patients with methicillin-resistant S. aureus ABSSSIs were 142 of 152 (93.4%) and 115 of 122 (94.3%), for ceftaroline and vancomycin plus aztreonam, respectively, and did not differ from those achieved in infections due to methicillin-susceptible S. aureus (93.0%-94.5%).
  • [MeSH-minor] Clinical Trials as Topic. Humans. Pneumonia, Bacterial / drug therapy. Staphylococcal Skin Infections / drug therapy

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22903949.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Cephalosporins; 0 / PPI-0903
  •  go-up   go-down


100. Bultink IE, Hamann D, Seelen MA, Hart MH, Dijkmans BA, Daha MR, Voskuyl AE: Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther; 2006;8(6):R183
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus.
  • Recently, the lectin pathway of complement activation has also been suggested to play a role in the occurrence of infections in SLE.
  • In previous studies, SLE patients homozygous for mannose-binding lectin (MBL) variant alleles were at an increased risk of acquiring serious infections in comparison with patients who were heterozygous or homozygous for the normal allele.
  • This association suggests a correlation between functional MBL level and occurrence of infections in SLE patients.
  • We therefore investigated the biological activity of MBL and its relationship with the occurrence of infections in patients with SLE.
  • Charts were systematically reviewed to obtain information on documented infections since diagnosis of SLE.
  • Major infections were defined as infections requiring hospital admission and intravenous administration of antibiotics.
  • In total, 115 infections since diagnosis of lupus, including 42 major infections, were documented in the 103 SLE patients (mean age 41 +/- 13 years, mean disease duration 7 +/- 4 years).
  • Although deposition of C4 to mannan and MBL pathway activity were reduced in 21% and 43% of 103 SLE patients, respectively, neither functional MBL serum levels nor MBL pathway activity was associated with infections or major infections in regression analyses.
  • In conclusion, SLE patients frequently suffer from infections, but deficiency of functional MBL does not confer additional risk.
  • [MeSH-major] Bacterial Infections / epidemiology. Lupus Erythematosus, Systemic / immunology. Lupus Erythematosus, Systemic / microbiology. Mannose-Binding Lectin / blood. Mannose-Binding Lectin / deficiency

  • Genetic Alliance. consumer health - Lupus.
  • Genetic Alliance. consumer health - Systemic lupus erythematosus.
  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Lupus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Rheum. 2000 Jul;43(7):1657-8 [10902774.001]
  • [Cites] Arthritis Rheum. 2005 Dec;52(12):3966-74 [16320344.001]
  • [Cites] Rev Immunogenet. 2000;2(3):305-22 [11256742.001]
  • [Cites] Lupus. 2001;10(7):505-10 [11480850.001]
  • [Cites] Lancet. 2001 Aug 25;358(9282):614-8 [11530147.001]
  • [Cites] Lancet. 2001 Aug 25;358(9282):637-8 [11530153.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Nov;86(11):5383-8 [11701711.001]
  • [Cites] Ann Rheum Dis. 2001 Dec;60(12):1141-4 [11709457.001]
  • [Cites] Genes Immun. 2001 Dec;2(8):442-50 [11781711.001]
  • [Cites] Scand J Immunol. 2002 Jan;55(1):105-10 [11841698.001]
  • [Cites] Lupus. 2002;11(4):234-9 [12043887.001]
  • [Cites] Mol Immunol. 2003 Jan;39(11):655-68 [12493641.001]
  • [Cites] Trends Immunol. 2003 Mar;24(3):148-54 [12615211.001]
  • [Cites] Mol Immunol. 2003 Sep;40(2-4):73-84 [12914814.001]
  • [Cites] Arthritis Rheum. 2003 Nov;48(11):3159-67 [14613278.001]
  • [Cites] Arthritis Rheum. 2004 Jan;50(1):151-9 [14730611.001]
  • [Cites] Mol Immunol. 1988 May;25(5):485-94 [3261834.001]
  • [Cites] Curr Opin Rheumatol. 1991 Oct;3(5):722-30 [1751307.001]
  • [Cites] Arthritis Rheum. 1992 Jun;35(6):630-40 [1599520.001]
  • [Cites] Clin Exp Immunol. 1992 Oct;90(1):31-5 [1395098.001]
  • [Cites] Clin Exp Rheumatol. 1992 Sep-Oct;10(5):541-7 [1458710.001]
  • [Cites] J Rheumatol. 1992 Oct;19(10):1559-65 [1464868.001]
  • [Cites] J Immunol Methods. 1993 Jul 6;163(1):67-76 [7687639.001]
  • [Cites] Semin Arthritis Rheum. 1993 Aug;23(1):16-21 [8235662.001]
  • [Cites] J Rheumatol. 1994 Jan;21(1):84-6 [8151595.001]
  • [Cites] Arthritis Rheum. 1995 Jan;38(1):110-4 [7818559.001]
  • [Cites] Arthritis Rheum. 1996 Mar;39(3):363-9 [8607884.001]
  • [Cites] Semin Arthritis Rheum. 1996 Apr;25(5):318-36 [8778988.001]
  • [Cites] Arthritis Rheum. 1996 Sep;39(9):1475-82 [8814058.001]
  • [Cites] Immunol Today. 1996 Nov;17(11):532-40 [8961631.001]
  • [Cites] BMJ. 1997 Apr 26;314(7089):1229-32 [9154025.001]
  • [Cites] Arthritis Rheum. 1997 Sep;40(9):1725 [9324032.001]
  • [Cites] Transfus Med. 1997 Dec;7(4):289-94 [9510927.001]
  • [Cites] Arthritis Rheum. 1999 Oct;42(10):2145-52 [10524686.001]
  • [Cites] Rheumatology (Oxford). 2005 Jan;44(1):111-9 [15479757.001]
  • [Cites] Ann Rheum Dis. 2005 Feb;64(2):311-4 [15647440.001]
  • [Cites] Eur J Immunogenet. 2000 Jun;27(3):111-7 [10940077.001]
  • (PMID = 17166254.001).
  • [ISSN] 1478-6362
  • [Journal-full-title] Arthritis research & therapy
  • [ISO-abbreviation] Arthritis Res. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Complement C4; 0 / Mannose-Binding Lectin
  • [Other-IDs] NLM/ PMC1794530
  •  go-up   go-down






Advertisement